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                                                   ABSTRACT 
STUDY: Correlation between excessive early pregnancy weight gain and risk 
of gestational diabetes mellitus 
GUIDE: Dr.Maya Menon., DNB (O&G) 
CO GUIDE:Dr.K.Mythili.,M.D .,DNB (O&G) 
 
Objective 
To study the correlation between excessive early pregnancy weight gain and the risk of 
developing gestational diabetes mellitus and its complications. 
Methods 
This is a prospective observational study  conducted in pregnant women attending antenatal 
outpatient Department in ESIC Medical College – PGIMSR ,K.K. Nagar,Chennai-78. Maternal 
weight gain from prepregnancy (self-reported) to 14 weeks of gestation was measured, and 
expected gestational weight gain was determined using the Institute of Medicine (IOM) 2009 
guidelines. Excessive early pregnancy weight gain was defined as gestational weight gain greater 
than the upper range of the IOM guidelines for first trimester(>2kg). Risk of developing  GDM, 
and its maternal and neonatal complications were estimated  and compared between women with 
excessive early pregnancy weight gain and  non excessive early pregnancy weight gain (within 
or below IOM guidelines). 
Results 
 
A total of  250  women were studied. 104  women developed GDM. Excessive early pregnancy 
weight gain occurred in 88 (35.2%) women.Out of 104 women with GDM ,62 (59.6%) women 
with excessive early pregnancy weight gain and  42 (40%)  with normal weight gain developed 
GDM with  significant ‘p’ ≤ .0001 . Out of 146  women  26 (17.8%) with excessive early 
pregnancy weight gain ,did not develop GDM. Risk of GDM, maternal and neonatal 
complications were higher in women with excessive early pregnancy weight gain especially in 
the first trimester. 
Conclusions 
Our study population showed, excessive early pregnancy weight gain especially in the first 
trimester  is associated with risk of developing GDM, and its related maternal and neonatal 
complications. Excessive GWG can be represented as a modifiable risk factor.Lifestyle and 
dietary modifications can prevent GDM and its related complications.This costless early 
intervention can make healthy future generation. 
Key Words: GDM-Gestational Diabetes Mellitus,IOM-Institute Of  Medicine,GWG-
Gestational Weight Gain . 
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INTRODUCTION 
HISTORY 
               Until the mid 19th century diabetes was considered to be 
incompatible with successful pregnancy. Diabetes in pregnancy was 
considered as a major risk factor for serious maternal and fetal 
complications until 1922(1).During this period pregnancy was discouraged 
in young women with type 1 diabetes mellitus. Before 1922, only fewer 
than 100 pregnancies were reported in diabetic women.  The reported “ 
infant mortality rate  were more than 90% and  maternal mortality rate  
were of 30%”.But few years after the discovery of insulin, the efforts of  
Priscilla White and other pioneers created the subspeciality of diabetes in 
pregnancy which changed the outlook of the deadly disease .since 1980 
neonatal and maternal mortality started declining because of  better 
treatment protocols for maternal plasma glucose  control with self 
monitoring - blood glucose (SMBG) and HbA1C evaluation  and ultra 
sonogram  availability. 
               Concept of  Gestational Diabetes was developed in the middle 
of 19th century by a German physician  Bennewitz in 1824 ,who 
described a single case with diabetes following conception which 
disappeared after delivery(baby weighed 12 pounds and was told to be 
robust and healthy). The term Gestational Diabetes was first coined by 
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O’Sullivan in 1961, following the lead of the term metagestational 
diabetes by Hoet from Belgium.  
DEFINITION 
Gestational diabetes is defined as “any degree of glucose 
intolerance with onset or first recognition during pregnancy”. 
Pathophysiology 
Researchers quoted that “during pregnancy the  complicated  
changes in maternal intermediary metabolism for accommodating the 
needs of  growing fetus have major influence on maternal health and  
physiology”(2).During  first half of  pregnancy the changes occur which 
promote storage of energy and nutrients. It is a state of “facilitated insulin 
action” which stores energy in the form of fat. The accumulated energy 
stores can be used in second half of pregnancy for the demands of rapidly 
growing fetus. The second half of pregnancy is a state of “diabetogenic 
stress” which is developed because of insulin resistance in the mother. 
These  are due to  high hormone level [elevation of oestradiol, oestriol, 
oestrone, progesterone, cortisol, prolactin  and  HPL (main driver of 
insulin resistance)], delayed  disposal of glucose, elevated serum insulin 
(fasting) levels, and reduction in  insulin release after food(3,4). Insulin 
resistance in the mother decreases the  carbohydrate uptake by the 
maternal peripheral  tissues like adipose tissue  which diverts glucose to 
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the fetus. The free fatty acids and ketone bodies are used as fuels for 
mother’s energy requirements. Increased glucose uptake by the fetus 
results in low maternal fasting plasma glucose levels. In late pregnancy 
there is exaggeration of normal swing between fed-state anabolism and 
fasting catabolism compared to non pregnant individuals. During feeding 
there is compensatory hyperinsulinaemia as a result of  insulin 
resistance(1).In the fasting state blood glucose level falls more rapidly than 
non pregnant individuals resulting in accelerated lipolysis and ketone 
body formation known as “ accelerated starvation”(1). 
PATHOGENESIS OF GDM: 
Since the insulin  resistance  develops only during second  half of  
pregnancy, GDM seldom develops before this period. The insulin 
resistance results in  “Exhaustion of the β cell which reduces the capacity 
of the β cells to secrete required levels  of insulin to compensate for the 
insulin resistance induced by the progression of pregnancy and  therefore 
lead to the development of GDM”(1,5). 
The risk factors include obesity(6),metabolic syndrome, diabetes in 
first degree relative, age more than 25 years, member of high risk ethnic 
group(Asian, Indian origin),polycystic ovary syndrome, previous 
unexplained perinatal loss, birth of malformed baby and polyhydromnios 
in previous pregnancy(7). 
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Gestational Diabetes Mellitus is associated with severe maternal 
and fetal morbidity and mortality(8,9,10). The maternal 
complications(2,3,11,12) are pre eclampsia, polyhydramnios, increased 
caesarean delivery(13), perineal trauma, risk of type 2 diabetes in future. 
The fetal complications are macrosomia(14,15,16), birth trauma, prematurity, 
respiratory distress syndrome, neonatal metabolic complications  like 
hypoglycaemia, hyperbilirubinaemia, polycythaemia, hypocalcaemia, risk 
of diabetes in future  and metabolic syndrome(17,18,13,19,7,20). 
Future risk of diabetes in mother: 
GDM, though resolves in women after delivery, it persists in 5-
10% of women and 35-60% will develop type 2 DM within the next 
decade. So GDM can be considered as unmasking of future type 2 
DM(19,21). 
Risk of future diabetes in offspring 
Studies in pima Indians and other ethnic groups showed that  
infants of GDM develops type 2 DM during their 3rd decade and their risk 
of developing hypertension, central obesity and  low HDL were also 
found to be high(19,22). 
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Scenario in Indian population: 
Seshiah et al,(1) stated  in 2008 that  GDM was diagnosed  in 17.8% 
women in urban population, 13.8% in semi urban population  and 9.9% in 
rural population  in a  prospective study screened for GDM. Indian 
women reported highest frequency of GDM, compared to other ethnic 
groups in South Asian countries. The cause for raising prevalence rate in 
developing countries is related to urbanization, sedentary life style, 
dietary pattern change hypertension(23) and  raising prevalence of obesity. 
This increased rate implies that Indian population with greater incidence 
of diabetes mellitus and IGT are more prone for developing  GDM  and is 
at a relatively increased  risk of GDM. Recent multicentric study in India, 
showed highest prevalence of GDM in Tamilnadu and lowest in Kashmir. 
With the raising prevalence of  type 2 DM and IGT, the incidence of 
GDM will be expected to go up further. 
In our study the aim was to find out the “correlation between 
excessive early gestational weight gain and the risk of gestational 
diabetes mellitus” and its related maternal and fetal  complications. The 
increased  weight gain in early gestation accumulates fat in adipose tissue 
which increases  insulin  resistance and reduces the capacity of β cells, 
resulting in decreased insulin secretion which predisposes to GDM. 
Researchers  stated  that   “Avoidance of excessive weight gain  in 
early  pregnancy”(24,25,26,27,28) is an efficient method  to prevent GDM & 
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its complications. But  more studies are necessary to determine the 
possibility of  early intervention and the best protocols  for the  pregnant 
women to help and  meet the recommendations for gestational weight 
gain(25,29,30).  
BMI limit :  
 Indian IOM 2009 
Underweight <18.4 <18.5 
Normal 18.5  to 22.9 18.5to24.9 
Overweight 23 to  24.9 25to29.9 
Obese > 25 >30 
 
According to  IOM 2009, guideline Calculations assume a 1.1–
4.4 lb(2kg) recommended weight gain in the first trimester. 
(Modified from Institute of Medicine (US). Weight gain during 
pregnancy: re-examining the guidelines. Washington, DC. National 
Academies Press; 2009. ©2009 National Academy of Sciences.)(30) 
According to the Asian Indian guidelines, the waist circumference  
cut off  of  Indian men is  90 cm  (102 cm globally) and for Indian women  
is 80 cm( 88 cm at the international level). 
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Researches observed during  the last several years and stated that 
“Indian bodies and genetics  differ from their western counterparts as 
Indians have abdominal obesity compared to the western people whose 
bodies are uniformly obese”(31,32,33).This body constitution complicates 
and fix the  Indian in the high risk region  for  hypertension and 
diabetes(29,34).  
The importance of  weight and fitness guidelines, in Asian 
countries, was first assessed  in a  randomized study by the World Health 
Organisation's (WHO) sub-committee group  for obesity and metabolic 
syndromes (Syndrome X- heart disease, obesity and diabetes) in the Asia-
Pacific region in 2000(34). 
India compiled its weight and flab statistics for the first time 
officially, and the opinion is an important act to fight against obesity and 
its impact on Diabetes.  
SCREENING FOR GDM  AND DIAGNOSIS 
 Universal screening for GDM is necessary, as it is generally 
accepted that “women of Asian origin and especially  Indians are at a 
higher risk of developing GDM and future type 2 diabetes”.  
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World Health Organization Procedure 
World Health Organization (WHO) recommends , 2-hour 75 g oral 
glucose tolerance test (OGTT) with a plasma glucose concentration of 
greater than 140 mg/dL at 2 hours, similar to that of IGT (more than 140 
mg/dL and less than 199 mg/dL), outside pregnancy for diagnosis of 
GDM. 
Time 
Normal 
Tolerance 
Impaired 
glucose 
tolerance 
Diabetes 
Fasting <100 ≥100 and<126 ≥126 
2 hour post 
glucose <140 ≥140 and<200 ≥200 
 
CARPENTER & COUSTON (1982) : DIAGNOSIS OF GDM BY 
100G 3-HOUR OGTT 
GDM is categorized, if any two values or met or exceeded. If only 
one value is abnormal, it is labeled as gestational impaired glucose 
tolerance. 
Fasting 95 mg/dl 
1 hour 180 mg/dl 
2 hour 155 mg/dl 
3hour 140 mg/dl 
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The International Association of the Diabetes and 
Pregnancy Study Groups (IADPSG) 
The IADPSG recommends that diagnosis of GDM is made “when 
any one of the  following plasma glucose values meet or exceed” (19):  
OGTT is done in the morning after overnight fast of at least eight 
hours 
Fasting    ≥ 92 mg/dL (5.1 mmol/L) 
1hour    ≥ 180 mg/dL (10.0 mmol/L ) 
2hour    ≥ 153 mg/dL  (8.5 mmol/L)  
 
• The IADPSG also suggests: 
* Fasting plasma glucose: (FPG)>7.0mmol/L (126 mg/dL)  
* HbA1C > 6.5% - in the early weeks of pregnancy is 
 diagnostic of overt diabetes.  
* Fasting plasma glucose  : > 5.1 mmol/L and < 7.0 mmol/L is 
 diagnosed as GDM.  
Disadvantages of the IADPSG suggestions are: 
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  Fasting state at first antenatal visit is impractical . 
 In all GDM, fasting plasma glucose values donot reproduce the 2-
hour postglucose (with 75 g oral glucose) , which is the hallmark of 
GDM in Asian Indian women. In this population by following FPG 
> 92 mg/dl as cut-off value, 76% of pregnant women will be 
missed for  the diagnosis of GDM made by WHO criteria. 
Diabetes in Pregnancy Study Group India : A single step procedure 
 “A Single-step procedure was developed  because of  the practical 
difficulty in  doing  glucose tolerance test in the fasting state”(1,2).  
Procedure 
A pregnant woman after  clinical examination, has to be given a 
75g oral glucose load, irrespective of  fasting or nonfasting state or the 
time of the last meal. A venous blood sample is collected at 2 hours for 
calculating plasma glucose by the GOD-POD method. GDM is diagnosed 
if 2-hour PG is ≥ 140 mg/dL . 
Advantages of the DIPSI procedure are: 
• No need  for  fasting state. 
•  pregnant woman’s routine activities are not affected. 
•  Screening and diagnostic procedure. 
• This procedure has been approved by Ministry of  
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 Health, Government of India and recommended by WHO. 
 DIPSI guideline for diagnosis of GDM, according to 75g oral 
glucose tolerance test (WHO criteria) 
Criteria In Pregnancy Outside Pregnancy 
2hr  ≥200mg/dl Diabetes Diabetes 
2hr  ≥140mg/dl GDM IGT 
2hr ≥120mg/dl DGGT - 
 
Abbreviation: 
GDM: Gestational diabetes mellitus; DGGT: Decreased gestational 
glucose tolerance; IGT: Impaired glucose tolerance 
In this study GDM was diagnosed according to DIPSI (Diabetes in 
pregnancy study   group in India) guidelines where the 2 hr post prandial 
glucose level more than 140 mgs is diagnosed as GDM. 
Cunningham  FG et al in Williams Text Book of Obstetrics (24th 
edition,2014) (35),quoted weight gain recommendations according to the 
Institute of  Medicine (2009) guideline(30),which was endorsed by  the 
American Academy of  Pediatrics and the American College of Obstetrics 
and Gynaecologists (2012) .The guideline recommends narrow range 
of  weight gain for obese women. Also the same recommendations 
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apply to adolescents, short women and women of all racial and ethnic 
groups. 
According to Williams Text Book of Obstetrics (24th edition,2014)  
early gestation  ( first trimester) corresponds to  14 weeks gestation.(30) 
So in our study, Gestational weight gain more than 2 kg( upper 
limit of IOM 2009 recommended weight gain for I st trimester) till 14 
weeks , was taken as excessive early gestational weight gain. 
Waist hip ratio: 
World Health Organisation  protocol: It should be measured at the 
midpoint between lower margin of the last palpable rib and the top of the 
iliac crest with a tape. Hip circumference should be measured around the 
widest portion of the buttocks, with the tape parallel to the floor. The 
WHO(World health organization) states that “ abdominal obesity is 
defined as a waist–hip ratio above 0.90 for males and above 0.85 for 
females, or a body mass index(BMI) above 30.0”(46,33).     
Since gestational diabetes mellitus is related with adverse maternal 
and fetal outcomes, protocol for management of GDM is essential. 
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MANAGEMENT OF GDM: 
Target 
Sustaining  a mean plasma glucose (MPG) level ~105–110 mg/dL 
is appropriate  for a good neonatal outcome(48,49). This can be achieved if  
fasting blood sugar and 2-hour postprandial peaks are ~90 mg/dL and 
~120 mg/dL, maintained respectively(39). 
Medical Nutrition Therapy 
All pregnant women with GDM should be counselled about proper 
nutrition. The recommended calorie intake depends on the pre pregnancy 
body weight, 30 kcal/kg for the normal weight pregnant women, 35 
kcal/kg for underweight and 25 kcal/kg for obese women. The total 
calories (3 meals and 3 snacks) should be contributed by about 50-60% 
from carbohydrates, 20% from protein and 25-30% from fats with less 
than 10 % from saturated fats (51, 52). 
INITIATING INSULIN THERAPY 
After the diagnosis of GDM, medical nutritional therapy (MNT) is 
recommended initially for 2 weeks(44). If there is no adequate response to 
MNT to maintain control, i.e. FPG ~90 mg/dL and/or post-meal glucose 
~120 mg/dL, insulin may be started(39).  
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Preferable to start with Premix insulin 30/70  
Initial dose: 4 units before breakfast 
                       ↓ 
Every 4th day increase 2 units till 10 units 
                       ↓ 
If FPG remains > 90 mg/dL advise→6 units before 
breakfast and 4 units before dinner 
                       ↓ 
Review with blood sugar test →Adjust dose further 
Total insulin dose per day can be divided as two-thirds in the 
morning and one-third in the evening. The morning dose is constituted by 
two thirds of intermediate acting insulin and one third regular or rapid 
acting insulin whereas the evening dose contains half intermediate and 
half regular insulin. 
Initially if post-breakfast plasma glucose is high → Start Premix 
50/50 
If GDM is diagnosed in the third trimester; MNT is advised for a  
week. Insulin is started if MNT fails. 
If 2-hour Postprandial glucose  > 200 mg/dL ,  8 units of  Premixed 
insulin can be started initially  before breakfast and the glucose level is 
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monitored and the  dose is  titrated on follow-up. With insulin therapy, 
Medical nutrition therapy should also be advised. 
INSULIN ANALOGS 
If postprandial glucose, control is not achieved— rapid acting 
insulin analogues should be considered. 
MONITORING GLYCEMIC CONTROL 
2-hour post prandial glucose monitoring is preferred as the 
diagnosis of GDM .The blood tests must be done at the same time at each 
visit for monitoring the target glucose level and adjusting insulin dose 
.Self-monitoring of blood glucose (SMBG) should be advised on day to 
day basis for the women who are not well controlled on multiple insulin 
injection regimen. If it fails at least weekly monitoring should be advised.  
ORAL ANTIDIABETIC DRUGS 
Glibenclamide is used in a few centers of India and abroad, but 
drug controller of India not yet approved the drug. 
Metformin 
Metformin  crosses  the placenta, but many observational studies 
on metformin used in early pregnancy have found no teratogenic effects 
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and can, therefore be used as an adjunct or alternative to insulin after 
counseling the patient.  
MEASURING OTHER PARAMETERS 
Maternal 
The blood pressure should  be checked during every antenatal visit. 
Fundus examination  and urine examination for microalbuminuria, every 
trimester is suggested  particularly in women with pregestational diabetes. 
Fetal surveillance:  
Ultrasonogram: Ultrasound monitoring is recommended once in a 
trimester atleast. Fetal echo should be done in second trimester 
particularly in women with pre GDM. 
Timing of delivery: 
                Patients with gestational diabetes well controlled on diet can be 
followed till 40 weeks, at that time induction of labour can be considered. 
Delivery before full term is  indicated for obstetric indications. Since 
GDM on insulin represents a greater degree of glucose intolerance 
pregnancy is usually terminated at 38-39 weeks(1).  
Delivery: 
During labor, maintaining good glycemic control is essential, and 
at the same time hypoglycaemia should be avoided. Insulin requirements 
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will become lesser in the process of labour (insulin may not be 
necessary).Monitoring of maternal blood glucose level should be done 
postnataly and 24 hours postpartum. If it is high, blood sugar level should 
be checked again on follow-up. The availability of neonataologist should 
be essential at the time of delivery if neonatal morbidity is suspected(1). 
FOLLOW-UP  
Gestational diabetic women requires follow-up. An OGTT should 
be performed at 6–8 weeks postpartum. If it is normal, glucose tolerance 
test is repeated after 6 months and annually. They should be counseled 
regarding diet, exercise and weight reduction which can reduce their 
chances or delay in developing type 2 diabetes later.                                                                       
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AIM 
 To study the correlation between the rate of excessive early 
gestational weight gain & risk for gestational diabetes mellitus. 
OBJECTIVE 
 To study  effects of abnormal weight gain in early pregnancy 
 To study the risk  of developing GDM  
 To study maternal complications  during delivery due to GDM 
 To study neonatal complications due to GDM 
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OUTCOME MEASURE 
Primary outcome:  
            To correlate the association between excessive early gestational 
weight gain and risk of developing GDM. 
Secondary outcome: 
           Maternal & Neonatal complications are compared between women 
developing GDM with excessive early gestational weight gain and 
normal gestational weight gain. 
Maternal complication: 
- Pre eclampsia 
- Induction of labour 
- Operational delivery 
- Polyhydominios 
Fetal complications: 
- Large for gestational age baby 
- Small for gestational baby 
- Birth asphyxia 
- Hyperbilirubinaemia 
- Hypoglycaemia 
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REVIEW OF LITERATURE 
EARLY PREGNANCY WEIGHT GAIN AND RISK OF GDM  
1. Herring et al (2009)(26) states that “ higher the GWG,  higher the 
risk  of developing GDM  in the third trimester of pregnancy”. 
They  observed that “maternal obesity and PostPartum Weight 
Retention (PPWR) have also been  associated with excessive 
GWG”. In addition to maternal outcomes, they also recognized that  
“excessive GWG has been associated with large for  gestational 
age (LGA) babies and excessive neonatal  weight” 
2. Hedderson MM et al(2010),(6)  studied  a multiethnic cohort of  
345 women with GDM and 800 women as control, delivered 
between 1996 and 1998, screened for GDM at 24–28 weeks of 
gestation. They found that the “association between gestational 
weight gain and risk of GDM was mainly attributable to excessive 
weight gain in the first trimester”  
3. Jeannine stein  2010(25) studied  Early-pregnancy Weight Gain 
association with Gestational Diabetes and declared “excessive 
weight gain during the first trimester can increase the risk of GDM, 
maternal and neonatal morbididy”. They concluded that “gaining 
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weight before conception or being overweight at the start of 
pregnancy results in  higher risk for gestational diabetes”. But a 
new study observed  that “first trimester is the most crucial time 
and excessive weight gain is the independent risk factor that can 
increase the danger of GDM” 
4. Zilko M et al (2010)(20) collected data from 4,496 births during 
1979 in the  National Longitudinal Survey of Youth and  described 
the “correlation between GWG and increased rates of  GDM, 
cesarean delivery , PPWR,  LGA as well as childhood overweight”. 
They concluded that, “40% of women with excessive GWG 
retained greater than 2.5 kg from 12 to 24 months after delivery 
and 29% of the children had a BMI greater than the 85th 
percentile” 
5. Metzger JJ  et al(2011)(18) conducted a study  to determine if 
women with normal glucose tolerance who gain weight beyond the 
2009 Institute of Medicine guidelines (based on pre-pregnancy 
BMI) have newborns with increased fat mass. Obese women 
gained weight beyond recommended guidelines (70% vs. 31%) 
than healthy weight women. Maternal fasting glucose, C-peptide 
(marker of insulin secretion) and leptin were significantly higher in 
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the excessive GWG group. Newborns of mothers with excessive 
GWG had significantly higher fat mass (490 vs. 390 g, p=0.04) and 
they tended to weigh more (3.61 vs. 3.38 kg). Neonatal length, 
abdominal circumference, cord blood glucose and leptin were 
similar between the groups, but cord blood C-peptide was 
definitely higher in the excessive GWG group. 
6. Morisset AS et al (2011)(46) conducted a study to “associate  
gestational weight gain in women and  GDM” The collected datas 
were retrospective reviews of medical records in 294 women. 
According to the 2009 recommendations by the Institute of 
Medicine (IOM), gestational weight was assessed. Women with 
GDM were treated according to the Canadian Diabetes Association 
guidelines. Compared to controls weight gain in the first trimester 
was significantly higher in GDM patient. They concluded that 
“First trimester gestational weight gain may need clinical 
intervention as it was identified as an independent and significant 
risk factor for GDM” 
7. Carreno CA et al(2012),(29) executed a randomized study on 7,985 
women who were studied to estimate the “ correlation  between 
excessive early gestational weight gain and the subsequent risk  of 
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gestational diabetes mellitus (GDM) and fetal macrosomia”. The 
studied population showed, excessive early pregnancy weight gain  
in 93% of women, where  the  total pregnancy weight gain more 
than the IOM guidelines. They also observed that in  nulliparous, 
low risk women, excessive early pregnancy weight gain is 
correlated with the risk of GDM and fetal macrosomia. They 
Concluded that “excessive early GWG (Gestational Weight Gain) 
is associated with adverse  outcomes including gestational diabetes 
mellitus, cesarean delivery and Large for gestational age baby in 
particular, the largest effect of excessive early pregnancy weight 
gain was found in women with a pre pregnancy normal BMI.” 
8. Devi NS et al (2014) (27) in May 2014, determined the “ prevalence 
of overweight and obese pregnant women, and maternal and fetal 
associations with overweight and obese pregnant women classified 
using the revised consensus guidelines for BMI in Asian Indians”. 
They analyzed  retrospectively case records between January 2010 
and December 2012 at a tertiary care institute in India. BMI was 
classified using the “revised consensus guidelines for Asian 
Indians and the World Health Organization (WHO) criteria”. The 
prevalence of obesity increased from 11.81% with the WHO 
criteria to 43.11% with the Asian Indian  guidelines and led to the 
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re-classification of 1,345 (18.47%) pregnant women from a low 
risk category to a high risk category. Maternal and fetal 
complications  were  associated with overweight or obesity (both 
Indian and WHO guidelines). Obesity (both Indian and WHO 
guidelines) was also significantly associated with caesarean 
sections. They concluded that  the “revised guidelines led to a 
larger classification of high risk Asian Indian pregnant women and  
retention of adverse associations of overweight and obesity support 
adoption of the revised guidelines in obstetric management of 
Asian Indians”. 
9. Egan AM et al(2014)(45) conducted  a  study  along the Irish 
Atlantic seaboard at five antenatal centers. 802 women with 
diabetes in pregnancy participated in this study. Maternal outcomes 
examined and  included  were  gestational hypertension, pre 
eclampsia and caesaerean delivery. Fetal complications  included  
were large for gestational age (LGA), fetal macrosomia, and small 
for gestational age(SGA).Excessive GWG was observed  in 59% of 
women. In all women, excessive pregnancy weight gain  resulted in 
increased odds for LGA  and macrosomia . Excessive pregnancy 
weight gain was also associated with an higher odds for gestational 
hypertension  in women with GDM. They concluded that “in the 
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“already high-risk odds for both GDM and PGDM (Pre Gestational 
Diabetes mellitus), excessive pregnancy weight gain confers an 
increased risk for LGA birth weight, macrosomia, and GHT ” 
BODY MASS INDEX 
10. Hedderson  MM et al (2008),(22) studied 123,040  women without  
history of pre GDM   between 1995 and 2006. The observation 
revealed “the risk of GDM, increased with increasing BMI”. They 
concluded that “the prevalence of GDM could be prevented if all 
pregnant women belongs to normal weight category according to 
IOM guideline ranging from 65% for Africo American women and 
for Asian women it is only 23% and the risk is more at relatively 
low BMI cutoffs in Filipina and Asian women”.  
11. Whiteman VE et al (2011)(31) observed  “whether changes in 
interpregnancy body mass index has any  influence on the 
development of  the  gestational and type 2 diabetes in  a cohort of 
women with two consecutive  live, singleton births of 20–44 weeks 
gestation”. Mothers who  progressed from a low BMI category into 
a high category had   risk for the developing diabetes and also 
mothers who progressed from  prepregnancy normal  weight in the 
first pregnancy to obese prepregnancy weight in the next  
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pregnancy showed  elevation  in risk. Mothers who maintained 
their interpregnancy BMI weight  or who progressed to a lower 
BMI category had decreased  risk for GDM and type 2 diabetes. 
They concluded that “ interpregnancy weight gain is associated 
with a  increase in risk of diabetes. Maintaining a normal 
interpregnancy BMI may decrease  the risk of diabetes” 
12. Alberico S et al (2014),(42)  conducted  a prospective study of 
14109 women  and associated with “ mode of delivery and 
maternal and neonatal outcomes to  evaluate the independent role 
of pre-pregnancy body mass index , gestational weight gain and 
gestational diabetes on the risk of  fetal macrosomia”. They 
concluded that “ maternal obesity, excess gestational weight gain  
and diabetes should be recognised as independent risk factors for 
fetal macrosomia” 
OBESITY 
13. Tovar A et al (2009)(6) conducted a prospective cohort study in 813 
Hispanic prenatal  patients in Massachusetts. In this prospective 
cohort study, they tried to associate “the role of gestational weight 
gain and development of AGT and found that exceeding target 
weight gain during pregnancy increased AGT risk only in women 
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with obese category”. They concluded that “weight gain was 
associated with AGT among class II and class III obese women”.  
14. The Institute of Medicine (2009)(30)  gives recommendation for  
total pregnancy  weight gain  based on prepregnancy BMI. These 
ranges are: 12.7 to18.1 kg for underweight, 11.3 to 15.9 kg for 
normal weight, 6.8 to11.3 kg for overweight and at least 6.8 kg for 
obese women (BMI > 29). The IOM also recommends “trimester-
specific weekly GWG again upon prepregnancy BMI, Specifically 
for the second and third-trimesters, and recommends 0.490 
kg/week for underweight women, 0.440 kg/week for normal 
weight women and 0.30 kg/week for overweight women”. 
15. Black MH et al (2013)(3) studied  10,459 women who met the 
IADPSG criteria.  They suggested  that “ prepregnancy overweight 
and obesity  contributes  to the prevalence of LGA, and  other 
adverse outcomes and  the effects of GDM and maternal BMI 
appear to be additive, but  only a small proportion of LGA cases 
were associated with GDM in the absence of overweight or 
obesity”.                               
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WAIST HIP RATIO AND GDM 
16.   Branchtein L et al (2001)(43) in 1997 evaluated  the “ relationship of 
central fat distribution with gestational glucose tolerance during the 
usual time for screening gestational diabetes”. Waist-hip ratio 
(WHR) and waist circumference were independently related with 
higher 2-h post prandial glycemia. They concluded that “Central fat 
distribution is an independent risk factor of gestational diabetes 
mellitus”  
17. Madhavan A et al (2009) (36) in 2008 observed that the prevalence 
of GDM was higher in pregnant women with higher waist–hip ratio  
compared with those having a lower WHR(Waist Hip Ratio). They 
observed that “waist circumference of 85.5 cm (with sensitivity of 
75%, specificity 81.4%) and a BMI of 24.3 kg/m2 (sensitivity 
75%, specificity 86.5%) had the best predictive value”. In 
conclusion, they  found  that “WHR is more important risk factor 
for GDM in overweight and obese women than women with 
normal weight and lean women” 
18. Basraon S et al (2015)(49) in 2013 determined  the “ relation of 
early pregnancy waist to hip ratio (WHR), a measure of central 
adiposity, versus body mass index (BMI), a measure of total body 
40 
 
fat, with abnormal glucose tolerance  and insulin resistance (IR)”.   
They concluded that “ increased WHR and BMI in early pregnancy 
are related with development of insulin resistance  and GDM” BMI 
is a better predictor of IR compared with WHR. 
FAMILY HISTORY OF DIABETES MELLITUS (FHD) 
19. Rethnakaran R et al  (2007)(3) investigated whether “ the family 
history of type 2 DM represents as a unique risk factor for GDM” 
GDM risk factors were evaluated in 90 women with FHD and in 83 
women without FHD, at the time of  OGTT (Oral glucose tolerance 
testing )in late pregnancy. They concluded that the “established risk 
factors for GDM are significant  in women with FHD but may not 
be the principal risk factor  of gestational hyperglycaemia in 
women without Family history of diabetes” Moreover, FHD may 
be more significant  to risk of GDM in nulliparous women than in 
parous women. They concluded that these findings highlight  
relationship between FHD and gestational diabetes mellitus, and 
may suggest implications for selective screening for GDM. 
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OPERATIONAL DELIVERY 
20. Cheng YW et al (2008)(47) conducted  a  retrospective  study of 
GDM  women with  singleton pregnancies  enlisted  between 2001 
and 2004  in the Sweet Success California Diabetes and pregnancy 
Program. This study investigated the “correlation between 
gestational weight gain and perinatal outcomes in women with 
GDM”. They concluded that “women with GWG  above the IOM 
guidelines were more likely to have a primary cesarean delivery 
and large birth weight, whereas women with less-than-
recommended weight gain were  likely to maintain glycemic 
control with dietary modifications  but had increased risk of SGA 
and suggests that excessive weight gain above the IOM guidelines 
is associated with abnormal perinatal outcomes”  
NEONATAL COMPLICATIONS. 
21. De Veciana M et al(1995)(21) investigated “66 women with 
gestational diabetes mellitus who are treated with  insulin therapy 
at 30 weeks of gestation or earlier and the women were randomly 
selected  to have their diabetes managed according to the results of 
preprandial  or postprandial  glucose monitoring (one hour after 
meals) of blood glucose concentrations”. They concluded that 
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“adjustment of insulin therapy in women with gestational diabetes 
according to the results of postprandial, rather than preprandial, 
blood glucose values improves glycemic control and decreases the 
risk of neonatal hypoglycemia, macrosomia, and cesarean 
delivery” 
22. Jovanovic-Peterson L et al (1997)(54)designed a study to “ observe 
the impact on birth weight and on cost of a treatment program for 
GDM women in The Santa Barbara County Health Care Services 
(SBCHCS)”. Based on the result  with  increasing glucose levels 
resulting in  increasing prevalence of fetal overgrowth. They 
observed that “After introduction of the screening and treatment 
program, the prevalence of macrosomia in 1992 was 7% and the 
cesarean section rate had dropped from 30 to 20%”. The cost  was 
$233,650 to educate and treat GDM women. They also assessed  
$833,870 per year can be saved if an additional 398 macrosomic 
infants were prevented from being born by good glycaemic control. 
They concluded that, “treatment of GDM women was associated 
with a decrease in risk of  macrosomia and may be cost-effective”. 
23. Negrato CA et al(2008)(34) conducted  this study to examine  “the 
prevalence of metabolic syndrome (MS) in a cohort of 136 
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pregnant women with  glucose tolerance, pre-pregnancy risk 
factors for MS during pregnancy and the  adverse perinatal 
outcomes”. They concluded that  the “prevalence of MS increases 
with the worsening of glucose intolerance and is an independent 
risk factor of adverse perinatal outcomes and impaired glycaemic 
profile identifies pregnancies with important metabolic 
abnormalities that are associated  with  adverse perinatal outcomes 
even in the presence of a normal OGTT, in patients that are not 
currently diagnosed  as having GDM”. 
24. Landon MB et al(2009)(44)studied  958 Women in the 24th to 31st 
week of gestation and who diagnosed as mild gestational diabetes 
mellitus  selected for usual prenatal care, dietary intervention, self-
monitoring of blood glucose, and insulin therapy. “The primary 
outcome was composed of stillbirth or perinatal death and neonatal 
complications, including hyperbilirubinemia, hyperinsulinemia, 
hypoglycaemia and birth trauma”. They concluded that “although 
treatment of mild gestational diabetes mellitus did not significantly 
reduce the frequency of a complex outcome, it reduced  the risks of 
fetal macrosomia, shoulder dystocia, cesarean delivery, and 
hypertensive disorders”. 
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25. Park JE et al (2011)(17) conducted  a hospital-based study of  
GDM women with  BMI of  ≥ 25 kg/m2.  Weight, glucose levels, 
lipid profiles, insulin treatment, and maternal outcomes were 
studied  and associated with neonatal birth weight. Excessive  
pregnancy weight gain resulted in fetal macrosomia, HbA1c at 
delivery, and PPBS levels, but pre prandial blood glucose levels 
were not affected . They concluded that “minimal weight gain, well 
below IOM recommendations, and strict control of blood glucose 
levels during pregnancy with proper medical management and 
dietary and lifestyle modification may alleviate most of the adverse 
outcomes in pregnancy experienced by obese GDM Asian 
women”.                          
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RELATED STUDIES 
26. Goldberg JD et al (1986) (15) studied two groups of 58 gestational 
diabetic women matched for age, parity, prepregnancy weight and  
height. The home glucose monitoring study group performed . The 
control group followed up by conventional treatment. The 
incidence of macrosomia was significantly reduced in the home 
glucose monitoring group. They concluded that “intensive home 
glucose monitoring will allow for the early identification of those 
gestational diabetic patients needing insulin and thus reduce the 
incidence of macrosomia and large for gestational age infants”. 
27. Langer O et al (1989)(14)  assessed  the relationship of  optimal 
levels of glycemic control and perinatal outcome in a study group 
matched for control of obesity, race, and parity. They concluded 
that “relationship exists between level of glycemic control and 
neonatal weight”. 
28. Wechter DJ et al(1991)(48) conducted a study  to “determine if 
intensive dietary therapy, home blood glucose monitoring, and the 
insulin can be effective in combating fetal overgrowth”. All 
pregnant women were screened at 24 to 28 weeks gestation using a 
modified O’Sullivan’s criteria. The 153 GDM patients advised on 
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an 1800 to 2000 Kcal, American Diabetes Association diet and 
taught home glucose monitoring. Insulin therapy started only if 
plasma glucose  control was insufficient. There were no significant 
differences (p > 0.05) between the study and control group with  
regard to mean birth weight or macrosomia. They conclude that the 
“incidence of fetal macrosomia in gestational diabetes can be kept 
equal to that of the general population by a program of intensive 
dietary therapy and home glucose monitoring, with insulin being 
used only therapeutically, not prophylactically” 
29. Pettitt DJ et al(1991)(39) studied  the “long-term effects on  the 
offspring of GDM women detected during pregnancy were 
examined in 552 Pima Indian offspring 5-24 yr of age”. Fasting 
hyperinsulinemia,  arise at the  earlier age in the offspring of  GDM 
women, and  they were  more obese and increasing rates of 
abnormal glucose level. They concluded that, “the metabolic 
abnormalities associated with the diabetic pregnancy results in 
long-term effects on the offspring, including insulin resistance, 
obesity, diabetes, which in turn may contribute to transmission of 
risk for developing the same problems in the next generation”.  
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30. Metzger BE et al (1991)(24)conducted a  multicenter, multinational 
study, to examine the association  of neonatal adiposity with 
plasma  glucose levels of pregnant women and cord serum C-
peptide thereby linking  the Pederson hypothesis of maternal 
glycemia and fetal hyperinsulinemia to neonatal adiposity. Among 
23,316 HAPO  Study participants , findings confirm the association 
between maternal glucose and neonatal adiposity and concluded 
that the “relationship is mediated by fetal insulin production and 
that the Pedersen hypothesis describes a basic biological 
relationship influencing fetal growth”. 
31. Catalano PM et al (1993)(4)  was conducted a  study  to 
“characterize carbohydrate metabolism associated with the 
development of gestational diabetes”. Insulin sensitivity decreased 
during gestation and was primarily decreased in GDM compared 
with control. They concluded that the “findings closely resemble 
those of non-insulin-dependent, predominantly insulin-resistant 
diabetes, which is often a sequel of GDM”. 
32. Mello G et al (1997)(50) studied the “relationship between perinatal 
outcome and daily glucose profile throughout pregnancy “. The 
study population  divided into two groups   Group I patients 
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without neonatal complications and Group II patients with at least 
one form of neonatal complications. They concluded  that “an 
optimum perinatal outcome can be achieved only if the pre-
pregnancy diabetic women can achieve a metabolic equilibrium 
during the second trimester which matches the daily excursions of 
glycemia present in a non-diabetic pregnant women avoiding 
individual episodes of night-time hypoglycaemia” . 
33. Bevier WC et al(1999)(16) studied pregnant women with  positive 
GCT, but  negative  3-hr,100g  OGTT. The  pregnant women were 
grouped into either experimental or control groups with 
experimental women receiving counseling regarding diet  and 
home blood  glucose monitoring instruction (HBGM). The aim of 
this study was to “examine the effectiveness of the treatment 
program in decreasing neonatal macrosomia, maternal and neonatal 
morbidity, maternal complications, and operative delivery”.  In 
Santa Barbara County,  pregnant women were screened  at 24-28 
weeks with a 50-g, 1-hr glucose challenge test  for GDM.  GDM 
women  were given standard euglycemic diet  and  perform HBGM 
of fasting and postprandial glucose levels. Women with abnormal 
GCT, but normal OGTT and thus not diagnosed as  GDM are still 
at risk for delivering a macrosomic baby and operative delivery. 
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They concluded that “treatment for all pregnant women with 
abnormal GCT improves outcome by reducing infant birth weight 
and the number of cesarean sections”  
34. Kang CH et al(2001)(37) conducted a retrospective study of “ 402 
GDM women with singleton pregnancies with cephalic 
presentation delivered at Ilsin Christian Hospital during the period 
January 1, 1997, to  December 31, 1999”. These women were 
compared with a nondiabetic control group  randomly selected and 
the effects of confounding variables were  analyzed and compared 
maternal behaviour and pregnancy outcomes. Pregnancy outcomes 
of gestational diabetic women were not improved by the  
conventional management, and more strict but acceptable and 
compliable treatment should be tried. 
35. Ben-Haroush A et al (2004)(49) conducted a study to “determine 
postprandial glucose profile in the diabetic pregnancy”. Pregnant 
women were connected to 72 consecutive hours continuous glucose 
monitoring system. They concluded that “the time interval for 
postprandial glucose peak in diabetic pregnancies is approximately 
90 minutes after meals throughout the day and is not affected by 
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the level of glycemic control and this information should be 
considered in the treatment of diabetes mellitus in pregnancy”. 
36. Brawarsky P et al (2005) (18)  conducted a  study in a group of  
pregnant women who completely answered the questions regarding  
diet and pregnancy weight gain and singleton full-term infant. 
Conclusion: “ Interventions to prevent excessive gestational weight 
gain should be started before pregnancy and women at risk for 
inadequate gain would also benefitted  from interventions directed 
toward modifiable factors during gestation.” 
37. Seshiah V et al (2008) (1) reported  practice guidelines for GDM in 
the Indian women. Due to increasing prevalence, screening by 
DIPSI is recommended. Screening is usually recommended 
between 24 and 28 weeks of gestation The maternal and fetal 
outcome depends on the care given  by the team of diabetologists, 
obstetricians and neonatologists. They concluded that “a short term 
intensive care gives a long term pay off in the primary prevention 
of obesity, IGT and diabetes in the offspring, as the preventive 
medicine starts before birth”.  
38. Hedderson MM et al(2008)(13)  conducted a study in  women with 
hypertension either 5 years before pregnancy or the first trimester 
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of pregnancy, had a twofold increased risk of developing GDM 
during pregnancy. While attenuated, these associations were 
persisted after adjusting for BMI. They implies that the 
“association is independent of BMI and the association between 
Blood pressure  and GDM was stronger among women who were 
overweight (BMI _25.0 kg/m2)”. 
39. Gayle C et al(2010)(11) concluded  that “ diagnosis of  GDM with 
OGTT 2-h PG ≥ 7.8 mmol/L  and treatment in a combined diabetes 
antenatal clinic is worthwhile with a decreased macrosomia rate 
and fewer emergency cesarean sections”.  
40. Balaji V et al(2011)(2)conducted a study, in which women were 
given 75 g oral glucose load irrespective of their last meal and 2-h 
PG ≥ 7.8 mmol/L were diagnosed as GDM. The explanation is that, 
“after a meal, woman with normal glucose tolerance  would be able 
to maintain euglycemia despite glucose challenge because of  brisk 
and adequate insulin secretion, but in  a woman with GDM who 
has impaired insulin response, her glycemic level increases with a 
meal and with glucose challenge”. This cascading effect is 
advantageous as this would not result in false positive diagnosis of 
GDM. In India more than 70% of population live in rural settings 
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and facilities for diagnosing DM  is limited. In this scenario, 
performing OGTT recommended by other associations [e.g., 
American Diabetes Association, National Diabetes Data Group, 
International Association of Diabetes and Pregnancy Study 
Groups] to diagnose GDM is not feasible as the cost involved is 
more to perform three blood tests and thus not accepted by both 
health care providers and seekers. DIPSI criterion suggests  
estimation of plasma glucose  level in one blood sample to 
diagnose GDM. This cost-effective and evidence-based procedure 
meets and offers “a single-step definitive glucose test” to all  
pregnant woman belonging to any socio-economic status. This 
study has validated the credibility of DIPSI criterion.  
41. Ehrlich SF et al (2011)(38) conducted a retrospective cohort  
analysis to correlate  the “ association between inter-pregnancy 
change in body mass index (BMI) and the risk of gestational 
diabetes (GDM) in a second pregnancy”.  22,351 women were 
studied and  women with inter-pregnancy BMI gains showed  an 
elevated risk of the disease  in the second pregnancy. They realised  
that “the loss of BMI units was associated with a decreased risk of 
GDM only in  women who were overweight/obese in the first 
pregnancy”. They concluded that “Inter-pregnancy increases in 
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BMI may elevate  a woman’s risk of GDM pregnancy, but 
reductions in BMI will be protective, particularly in overweight 
and obese women”.  
42.  Katon J et al (2013)(32) conducted  a retrospective cohort study  in  
“Overweight and obese women with live singleton pregnancies 
treated for GDM at a large diabetes and pregnancy program located 
in Charlotte, NC between November 2000 and April 2010”. The 
association of weight loss in GDM women and birth weight were 
examined  by maternal pre-pregnancy overweight or obesity class 
(I, II/III). Out of 322 women in the study 19 % lost weight between 
diagnosis of GDM and delivery. They concluded that “weight loss, 
after diagnosis of GDM, is associated with lower infant birth 
weight in overweight women, but not in obese class II/III women”. 
43.  Sivaraman SC  et al (2013)(5) conducted  this observational cohort 
study to  “determine the long term risk of diabetes in a cohort of 
women with previous GDM, and  investigate which ante-partum 
and post-partum factors are related with the size of the risk”. There 
was no correlation  with age, gestational age at diagnosis of GDM, 
and parity. They Concluded that “Women with fasting antenatal 
glucose ≥ 7.0 mmol/L and/or an antenatal two-hour glucose ≥ 11.1 
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mmol/L are at higher risk of developing GDM  and need close 
monitoring”. 
44.  Wendland EM et al (2013)(12) selected  two criteria of  World 
Health Organization (WHO), and International Association for 
Diabetes in Pregnancy Study Group (IADPSG),  generated in the 
HAPO (hyperglycaemia and adverse pregnancy outcome) study. 
The  aim is to “ review the evidence for the associations between 
GDM (according to these criteria) and adverse outcomes”. They 
concluded that “The WHO and the IADPSG criteria for GDM 
identified women at a small elevated  risk for adverse pregnancy 
outcomes and associations were of similar magnitude for both 
criteria”. 
45. Cunningham  FG et al (2014)(35)recommends  risk factors to 
decide which pregnant women to test for gestational diabetes . In 
these women, World Health Organization’s diagnostic criteria used 
for screening gestational diabetes. In women with history of  
gestational diabetes in a previous pregnancy, offer early self 
monitoring or an OGTT at 16-18 weeks and  at 28 weeks if the 
results are normal. They showed the association between risk 
factors and development of GDM. 
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46. Kuhl C (2014) (53)reviewed  ,collected data and observed  
additional informations from articles that the “ diabetogenicity of 
pregnancy is related to a increased  peripheral resistance to 
insulin”. They concluded that the “ resistance which is of similar 
magnitude in pregnant women with NGT(normal glucose tolerant 
women) and women with GDM, is caused by post insulin receptor 
events and it probably because of the effect brought about by 
cellular effects of the high plasma levels of  pregnancy associated 
hormones and free cortisol”.  
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MATERIALS & METHODS 
 STUDY DESIGN     
Prospective observational   study 
 SELECTION  
 Pregnant women attending antenatal  OPD in study centre (ESIC 
MC PGIMSR,K.K Nagar) 
   SAMPLE SIZE             
According to qualitative analysis  (n=4pq/l²)=250 patients. 
 STUDY PERIOD           
18 Months (NOV 2013 to MAY 2015) 
INCLUSION CRITERIA: 
 Singleton  pregnancy 
 Regular antenatal visits 
 No associated co morbidity  
EXCLUSION CRITERIA: 
 Multiple pregnancy 
 Anaemia complicating pregnancy 
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 chronic hypertension  
 Pregestational diabetes mellitus 
 Thyroid disorders complicating pregnancy 
 Molar pregnancy 
METHODS 
 Maternal weight gain from self reported  prepregnancy weight 
(upto 6 weeks) to 14 weeks of gestation is  measured. Maternal 
weight gain more than 2kg is considered as excessive early 
gestational weight gain. 
PROCEDURE 
 During first antenatal visit height, weight and waist & hip ratio is 
measured 
 Body mass index is calculated according to quetlet index(weight in 
kg/height in meter squared) 
 Categorisation of the pregnant women according to ASIAN 
INDIAN BMI guidelines. Detailed history, general examination 
and obstetric examination done. 
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1. Blood samples (6-8ml) will be taken for 
 Hb 
 Renal function test 
 Liver function test 
 HbA1C 
 Oral glucose challenge test (since fetal beta cell starts secreting 
insulin by 9-11 weeks gestation) 
FOLLOW UP: 
 monthly till 28 weeks/ fortnightly till 36 weeks/weekly till 
term(each time weight  is measured) 
 If the patient is not diagnosed as GDM in the first trimester, OGCT 
will be repeated at 24-28 weeks and 32-34 weeks gestation. 
 If diagnosed as GDM patient, she will be treated as per protocol. 
 Patient will be followed up till delivery 
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RESULTS 
STATISTICAL TOOLS USED: 
The information collected were recorded in a Master Chart in Excel 
sheet. Data analysis done with the help of computer using SPSS 
statistical package- Version 17.  
Using this software range, ‘t’ value and   'p'  values were calculated  
with frequencies, percentages, means, standard deviations. Student’s  ‘t’  
test was  used to test the significance of association between early 
pregnancy weight gain and quantitative variables. For qualitative 
variables  chi square test was used. A 'p' value less than 0.05 will denote 
significant relationship. 
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285 women who attended antenatal out patient department in ESIC 
MC PGIMSR , K.K Nagar were recruited  in the original trial. Out of 285 
women 12 antenatal women lost follow up, 8 women’s prepregnant 
weight report were not available and 15 women developed obstetrical 
complications like anaemia, hypothyroidism and molar pregnancy.  
In our study height measurements and self reported  prepregnancy 
weight  (upto 6 weeks gestation) to assess the BMI and  upto 14 weeks of 
gestation(35) were taken. The early gestational weight gain more than 2 kg 
(according to upper limit of IOM guideline for first trimester)(30) was 
considered as excessive weight gain and was correlated with developing 
risk of GDM .Of  the 250 women studied 104 women developed GDM 
who were compared with control of 146  women belonged to non GDM 
group . 
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The age distribution datas of the 250 women  are summarized in 
Table 1.The  age distribution had a high proportion between 25 -29 yrs 
and above 30 years are 58.  
Table 1 : Gestational DM and Age 
Gestational 
DM 
Age of Mother Age 
distribution 
Case 
Mean S.D. N % 
Yes 27.5 4.0 Below 20 yrs 5 2.0 
No 26.2 3.9 20 – 24 yrs 82 32.8 
‘p’ 0.0101 Significant 25 – 29 yrs 105 42.0 
   >30yrs 58 39 
   Total 250 100 
   Range 19 – 42 yrs 
   Mean 26.8 yrs 
 
 
 
 
 
 
 
 
 
The mean age for GDM observed  was 27.5 according to our study. 
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Table 2 : Gestational DM  & Parity 
Gestational DM 
Parity 
Primi Multi 
N % N % 
Yes (104) 56 53.8 48 46.2 
No (146) 67 45.9 79 54.1 
‘p’ 0.2662   Not Significant 
 
 
 
 
 
 
 
In this study there was no significant correlation demonstrated 
between parity and GDM 
123, 49%
127, 51%
PARITY
PRIMI MULTI
63 
 
Table 3 : Body Mass Index & Gestational DM 
Body Mass Index 
Gestational DM 
Yes No 
N % N % 
Underweight (< 18.4)(4) 0 0 4 100.0 
Normal ( 18.5 – 22.9 ) (185) 67 36.2 118 63.8 
Overweight ( 23 – 24.9) (35) 21 60.0 14 40.0 
Obese ( > 25 ) (26) 21 80.8 5 19.2 
‘p’ 0.0064 Significant 
 
 
 
 
 
 
 
 80% Obese women and 60% overweight women developed GDM  
and showed a significant correlation of  ‘p’ =.0064 
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Table 4 : Waist / Hip Ratio % and Gestational DM 
Waist / Hip Ratio % 
Gestational DM 
Yes No 
N % N % 
Normal (220) 82 37.2 137 62.3 
Abnormal (30) 22 73.0 8 27.0 
‘p’ 0.0015  Significant 
 
 
 
 
 
 
 
 
73% of the women with abnormal waist hip ratio developed GDM 
with significant correlation of  ‘p’ =.0015 
220, 88%
30, 12%
WAIST/HIP RATIO
NORMAL ABNORMAL
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Table 5 : Family History of DM  & Gestational DM 
Family History 
of DM 
Gestational DM 
Yes No 
N % N % 
Yes (83) 68 56.6 15 43.4 
No (167) 36 40.7 131 59.3 
‘p’ <0.0001   Significant 
 
 
 
 
 
 
 
56.6% of women with family h/o DM developed GDM with 
significant correlation of  ‘p’ = <0.0001.    
83, 33%
167, 67%
FAMILY HISTORY OF DM 
YES NO
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Table 6 : Gestational DM & Early Pregnancy Weight Gain 
Gestational DM 
Early Pregnancy Weight Gain 
Normal Abnormal 
N % N % 
Yes (104) 42 40.4 62 59.6 
No (146) 120 82.2 26 17.8 
‘p’ < 0.0001  Significant 
 
 
 
 
 
 
 
 
 
 62 women with excessive early pregnancy weight gain developed GDM 
with Significant correlation of ‘p’ < .0001. 
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Table 7 : Gestational DM & Type of Delivery 
Gestational DM 
Type of Delivery 
Normal LSCS 
N % N % 
Yes (104) 39 37.5 65 62.5 
No (146) 94 64.4 52 35.6 
‘p’ <0.0001   Significant 
 
 
 
 
 
 
                                                                                                            
Out of 104 women who developed  GDM, 62.5% had operational 
delivery which showed significant correlation ‘p’ < .0001. 
133, 53%
117, 47%
TYPE OF DELIVERY
NORMAL DELIVERY LSCS
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TABLE  8 :Pre eclampsia & GDM 
 
TOTAL PRE ECLAMPSIA 
GDM 104 24 (80%) 
NON GDM 146 6 (20%) 
 
 
Our study observed that  out of 30 women who developed 
preeclampsia , 24 were belonged to GDM group and 6 were non GDM. 
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TABLE 9 : INDUCTION OF LABOUR & GDM 
INDUCTION OF LABOUR GDM NON GDM 
77 52(67%) 25(33%) 
                                
 
Out of 77 women who were induced for labour,52 belonged to 
GDM group and 25 belonged to non GDM group. 
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Table 10 : Gestational DM & APGAR Score 
Gestational DM 
APGAR Score 
Mean S.D. 
Yes (104) 7.73 0.54 
No (146) 7.69 0.61 
‘p’ 0.6012 Not Significant 
 
 
 
 
 
 
 
 
 
Our study showed no significant association  in  relation to 
APGAR score. 
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TABLE 11:NEONATAL COMPLICATIONS: 
Neonatal Complications 
Cases 
N % 
Large for Gestational age 20 8.0 
Small for Gestational age 12 4.8 
Hypoglycemia 51 20.4 
Birth Asphyxia 19 7.6 
Hyper Bilirubin 69 27.6 
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Table 12:  NEONATAL COMPLICATIONS 
NEONATAL 
COMPLICATIONS 
TOTAL GDM NON GDM 
LGA 20 14 (70%) 6 (30%) 
SGA 12 4 (34%) 8(66%) 
HYPOGLYCAEMIA 62 51(82%) 11(18%) 
HYPERBILIRUBINAEMIA 69 43(62%) 23(38%) 
BIRTH ASPHYXIA 23 19(82%) 4(18%) 
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DISCUSSION 
In our  study  pregnant women were  given 75 g oral  glucose load 
irrespective of their fed state and 2hour post prandial glucose more than 
140 mgs were interpreted  as GDM. The explanation  is that, “after a 
meal, women with normal glucose tolerance  would be able to maintain 
normal glucose level despite glucose challenge because of  brisk and 
adequate insulin secretion, Whereas, a woman with gestational diabetes 
mellitus who has reduced  insulin response, her glucose level increases 
with a meal and with glucose challenge and the glycemic excursion 
exaggerates further(23,30)”. This cascading effect is convenient as this 
would not result in false positive diagnosis of GDM. Gestational weight 
gain more than  2 kg till 14 weeks(35) ,according to IOM(30,10) guidelines 
was taken as excessive early gestational weight gain.  
In our study, we found that excessive early gestational weight gain 
in early pregnancy, particularly in the first trimester was associated with 
increased risk of GDM. 
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AGE: 
In our study 58 women were in the age group >30 yrs, 31(53 %) of 
them developed GDM. And also in our study the mean age group is 27.5 
yrs  who developed GDM, which is in favour  as the age advances the 
risk of developing  GDM also increases (P=.0101) 
Parity:  
In our study 123 of the enrolled population were primis of which 
56 women(53.8%)   developed GDM and 127  of the population were 
multi paras of which 48 women (46.3%) developed GDM which has no 
significant correlation.(P=.2662) 
BODY MASS INDEX: 
In our study underweight women with BMI ≤ 18.4 were 4 and none 
of them developed GDM .Women with normal BMI  between (18.5-22.9) 
were 185 and in this population 36.2% developed GDM ,63.8% did not 
develop GDM. Overweight women with BMI between ( 23-24.9) were 
35,out of which 21(60%) developed GDM and 14 (40%) did not develop 
GDM. Obese women with BMI(≥25) were 26  out of which 21(80.8%) 
developed GDM  and 5 (19.2%) did not develop GDM(40). Carreno CA et 
al in 2012(29) and Hedderson MM et al in 2010(28,41) Valerie C Whiteman 
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et al (31), Alberico(42) reported similar findings that the correlation  was 
greater among overweight and obese women. 
STUDY  (Et al) P Value 
Monique Hedderson(28) <0.001 
Valerie C Whiteman(31) <0.002 
Alberico(42) <0.001 
This study 0.0064 
 
WAIST HIP RATIO: 
Out of 250 enrolled women 30 women were with abnormal waist 
hip ratio and 22(73%) women developed GDM which has a significant 
correlation with P value of  .0015. Sanmorn Basraon et al,(33) Leandro 
Branchtein et al,(43) Anju madhavan et al(36) al also showed similar 
correlation. 
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STUDY  (Et al) P Value 
Sanmorn Basraon (33) <0.02 
Leandro Branchtein(43) <0.01 
Anju madhavan(36) <0.003 
This study 0.0015 
 
FAMILY HISTORY OF DM: 
In our study out of 250 women enrolled  68 (56.6 % )of the women 
with family history of DM developed GDM and 15 (43.4%) did not 
develop GDM .In our study the representative population showed  
significant correlation  between GDM and family history of DM. Ravi 
Rethanakaran et al(3) study  shows similar correlation. 
STUDY  (Et al) P Value 
Ravi Rethanakaran(3) <0.02 
This study <0.0001 
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EARLY PREGNANCY WEIGHT GAIN: 
In our study we realised that the correlation of GWG and  risk of 
GDM was strongly attributable to increased weight gain in the first 
trimester(29). “Excessive gestational weight gain in early pregnancy causes 
increased insulin resistance and leads to exhaustion of the B cell which 
reduces the capacity of  B cells to secrete required insulin response to 
compensate for the insulin resistance induced by progression of 
pregnancy and development of GDM”. 
In our study 88 women with excessive early pregnancy  weight 
gain , of which 62(59.6%) developed GDM and 26 (17.8%) did not 
develop GDM  with P value of  ≤ .0001,which shows a strong association 
between excessive early pregnancy weight gain and risk of GDM. The 
following researchers showed similar association. 
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STUDY  (Et al) P Value 
Hedderson(28) <0.001 
Carlos A  Carreno(29) <0.001 
Aoife M Eagen(45) <0.001 
Morrisset As(46) <0.002 
Herring(36) <0.001 
Margerison <0.002 
Jeanine stein(25) <0.001 
Josefson J Metzger(18) <0.03 
This study <0.0001 
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MATERNAL COMPLICATIONS 
MODE OF DELIVERY: 
                In our study out of 104 women who developed GDM ,39 
(37.5%) women delivered normally and 65 (62.5%) women delivered 
through LSCS.As GDM increases the risk of caesarean delivery, our 
study showed significant correlation with ‘p’ value of <0.0001 
STUDY  (Et al) ‘p’ Value 
Cheng Yvonne (47) <0.01 
This study <0.0001 
 
INDUCTION OF LABOUR: 
               Out of 77 women in whom induction of labour was done with 
prostaglandin E2 gel, 52(67% )were women with GDM.  
Pre eclampsia:  
             Our study observed that out of 30 women who developed 
preeclampsia, 24 (80%) were belonged to GDM group and 6 (20%) were 
non GDM. 
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POLYHYDROMINIOS: 
In our study  out of 104 women who developed GDM ,6 women 
developed polyhydramnios and 2 of them developed preterm labour due 
to pre mature  rupture of membrane. 
NEONATAL COMPLICATIONS 
In our study,20 babies belonged to large for gestational age group 
with birthweight  more than 3.5 kg in which 14(70%) babies were born to 
GDM mothers and 6(30%) were born to non GDM mothers. out of 12 
small for gestational age babies 4(34%),belonged to GDM  mothers and 8 
(66%)belonged to non GDM mothers. 51(82%) babies born to GDM 
mothers developed hypoglycaemia and required  NICU admissions. Out 
of 69 babies who developed hyperbilirubinaemia 43(62%) were born to 
GDM mothers and 23(38%) were born to non GDM mothers.19 babies 
developed birth asphyxia and got admitted in NICU. 
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SUMMARY 
Gestational DM and Age: 
This study shows the age distributions with high proportion 
between 25 -29 yrs and above 30 years are 58. 39% of women are above 
30 yrs of age  and in this age group 31(53%) women developed GDM. 
The mean age for GDM observed was 27.5 according to our study. 
Gestational DM & Parity: 
            In this study 56(53.8%) were primi and 48(46.2%) were multi, 
who developed GDM, and there is no significant correlation between 
these two variables (P value .2662) 
Body Mass Index & Gestational DM:  
           In this study, out of 26 obese women, 21(80%) pregnant women 
developed GDM and Out of 35 overweight women, 21(60%) developed 
GDM. In this study overweight and obese women demonstrated 
significant correlation for developing GDM with P value of .0064. 
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Waist / Hip Ratio % and Gestational DM:  
            In our study 37.2% of women developed GDM with normal waist 
hip ratio and 22 (73%) developed GDM with abnormal waist hip ratio 
with significant correlation of P =.0015 
Family History of DM & Gestational DM:  
              In our study 56.6% of women with family history of DM 
demonstrated a significant association with regard to rate of GDM with 
significant correlation of   P = <0.0001 
Gestational DM & Early Pregnancy Weight Gain:  
              In this study, out of 88 women enlisted had excessive early 
gestational weight gain. 26(17.8%) normoglycaemic women, gained 
excessive weight during first trimester and 62(59.6%) of women with 
excessive weight gain developed GDM with significant correlation of P 
value < .0001.  
Gestational DM & Type of Delivery:  
             In our study,Out of 104 women who developed GDM,65 (62.5%) 
women had operational delivery,39 (37.5%) had normal delivery with 
significant correlation of  P value <0.0001 
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Gestational DM and Pre eclampsia:  
Our study observed  that out of  30 women who developed 
preeclampsia, 24 (80%) were belonged to GDM group and 6 (20%) were 
non GDM. 
Gestational DM  and Induction of labour:  
           In this study,Out of 77 women who were induced for labour,52(67%) 
belonged to GDM group and 25(33%) belonged to non GDM group. 
Gestational DM & APGAR Score: 
Our study showed no significant correlation with apgar score with 
insignificant P value of .6012 
Gestational DM and Neonatal complications: 
                In our study, 20 babies belonged to large for gestational age 
group with birth weight  more than 3.5 kg in which 14(70%) babies were 
born to GDM mothers and 6(30%) were born to non GDM mothers. Out 
of 12 small for gestational age babies 4(34%) belonged to GDM 
mothers and 8(66%) belonged to non GDM mothers.51 (82%) babies 
born to GDM mothers developed hypoglycemia and required NICU 
admissions. Out of 69 babies who developed hyperbilirubinaemia 43 
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(62%)were born to GDM mothers and 23(38%) were born to non GDM 
mothers.19(82%) babies developed birth asphyxia and got admitted in 
NICU and  4(18%) babies were belonged to non GDM group. 
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CONCLUSION 
               Excessive early pregnancy weight gain, primarily in the first 
trimester may increase a women’s risk of GDM and it’s related maternal 
and fetal complications. Excessive gestational weight gain can be 
represented as a modifiable risk factor occurring during early 
pregnancy(6). Lifestyle modifications like simple excercises (walking) and 
dietary modifications can prevent GDM and it’s related complications. 
This costless early intervention can make healthy future generations(54). 
Monique M. Hedderson et al(28), Herring et al in 2009(26), 
Margerison et al in 2010, Jeannine stein in feb 2010(25), Sallyn Boyles 
investigated the correlation  between excessive early gestational weight 
gain and the risk of gestational Diabetes mellitus and they demonstrated 
the stronger correlation  between weight gain during the first trimester 
and  GDM.They also demonstrated  there was no association between 
weight gain during the second trimester and getstational diabetes mellitus. 
            Hedderson said “As all pregnancies progress an increase in insulin 
resistance occurs” due to decreased  β cell capacity caused by excessive 
weight gain”. And also prepregnant obesity could be a high risk factor for 
developing GDM that any increased weight gain during first trimester 
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will thrust them into GDM. So early interventions of life style 
modifications can have a big impact on reducing GDM and it’s related 
complications. 
         Cuilin Zhang and Yining et al(51) in may 2011 studied the effect of 
dietary modification and excercises on the risk of developing  GDM. The 
collected datas were investigated on the basis of Nurses’ Health Study II. 
They suggested that “high fibre intake and polyunsaturated fat intake a 
may guard against glucose intolerance during pregnancy, and increased 
intake of saturated fat may be harmful”. In an another prospective 
observational study of pregnant women, decreased vitamin C and vitamin 
D concentrations in the plasma  were significantly associated with 
increased risk of GDM. They also observed 30 minutes of brisk walking 
reduces the risk of developing GDM.  
           Thobias DK et al, (52) in 2014 quantified the correlation between 
combination of healthy lifestyle modifications before and during 
pregnancy (recommended weight, dietary habits, daily exercise, and no 
smoking) and the risk of gestational diabetes. They concluded that, 
“adopting a healthy lifestyle in the period before and during pregnancy is 
associated with a substantially lower risk of gestational diabetes”.  
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           From our study, we conclude that excessive early pregnancy  
weight gain   especially  in the  first trimester  correlates with developing 
the complication of GDM. Thus preventing excessive early pregnancy 
weight gain in the first trimester  which can be modified by lifestyle 
changes and simple exercises  which is a costless intervention  supported 
by the studies of researchers  may decrease maternal and neonatal 
morbidity effectively. So here are some advises for the pregnant women 
to reduce excessive weight gain during pregnancy. 
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ADVISE FOR CONTROLLING EXCESSIVE WEIGHT GAIN IN 
PREGNANCY 
 Consuming regular meals and small healthy snacks between meals 
(3 meals and 3 snacks), will also help controlling pregnancy related 
nausea. 
 Avoiding  sweets and sweetened drinks 
 Consuming only about 100 to 300 calories a day 
 Reducing  fat intake  
 Drinking  less fruit juice and eat more whole fruit 
 Consuming  food high in fiber 
 Decrease white flour products like white bread and cereals 
 Consuming whole grain foods 
 Avoiding fried foods 
 Choosing  grilled or baked foods 
 Meals should not be skipped 
 Being active 
 30 min of exercise on most days of the week( swimming, brisk 
walking, indoor stationary cycling,  and low-impact aerobics) 
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LIST OF ABBREVIATION 
 
1.SMBG   - SELF MONITORING - BLOOD GLUCOSE 
2.GDM                   - GESTATIONAL DIABETES MELLITUS 
3.HPL   - HUMAN PLACENTAL LACTOGEN 
4.DM                     - DIABETES MELLITUS 
5.IGT                   - IMPAIRED GLUCOSE TOLERANCE 
6.IOM                    - INSTITUTE OF MEDICINE 
7.WHO                 - WORLD HEALTH ORGANISATION 
8.OGTT                    -  ORAL GLUCOSE TOLERANCE TEST 
9.OGCT                   -  ORAL GLUCOSE CHALLENGE TEST 
10.IADPSG      - THE INTERNATIONAL ASSOCIATION OF  
THE DIABETES AND PREGNANCY STUDY 
GROUPS 
11.DIPSI       - DIABETES IN PREGNANCY STUDY GROUP 
    INDIA 
12.GWG         - GESTATIONAL WEIGHT GAIN 
13.PPWR          - POSTPARTUM WEIGHT RETENTION 
14.LGA                 - LARGE  FOR GESTATIONAL AGE 
15.SGA                - SMALL FOR GESTATIONAL AGE 
16.BMI                - BODY MASS INDEX 
17.WHR             - WAIST HIP RATIO 
18.MNT           - MEDICAL NUTRITION THERAPY 
19.FPG             - FASTING PLASMA GLUCOSE 
20.GOD-POD     - GLUCOSE OXIDASE- PEROXIDASE 
21.MPG           - MEAN PLASMA GLUCOSE 
22.IR                 - INSULIN RESISTANCE 
23.AGT            -  ABNORMAL GLUCOSE TOLERANCE 
 
 
99 
 
PROFORMA 
                                                      
 NAME:                                              LMP: 
 AGE   :                                                         EDD: 
 SEX    :   
 SOCIO ECONOMIC STATUS                     HEIGHT: 
 PARITY:                                                      PREPREGNANCY WEIGHT:    
                                                                                 BODY MASS INDEX :   
 GESTATIONAL AGE :  
   MENSTRUAL HISTORY 
 MARITAL HISTORY 
 OBSTETRIC HISTORY 
 PAST HISTORY 
 FAMILY HISTORY 
 GENERAL EXAMINATION 
 PER ABDOMEN EXAMINATION: 
 WEIGHT GAIN                   1st TM                2nd TM              3rd TM 
 OGCT VALUE 
                                     PREGNANT WOMEN 
          GROUP A                                                            GROUP B 
  
    NORMAL WEIGHT                                            EXCESSIVE WEIGHT 
          GAIN                                                                           GAIN 
                                                                       
GDM             NO GDM                                        GDM                     NO GDM 
 MATERNAL OUTCOME 
             GDM 
             NORMAL DELIVERY 
             INDUCTION OF LABOUR 
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              CAESAREAN SECTION   
               PRE ECLAMPSIA                     
 FETAL OUTCOME 
               LGA 
    SGA 
               HYPOGLYCAEMIA 
               BIRTH ASPHYXIA 
               HYPERBILIRUBINAEMIA  
RESULTS 
 
Statistical Analysis Plan 
 
Results will be assessed and tabulated  using SPSS EXCEL SOFTWARE System. 
 
Signature of the investigator: 
Signature of the Patient: 
Witness:                    
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PATIENT CONSENT FORM 
STUDY TITLE: CORRELATION OF EXCESSIVE EARLY PREGNANCY 
WEIGHT GAIN AND RISK OF GESTATIONAL DIABETES MELLITUS 
Study center:           ESI PGIMSR  
Participant name :            age:           sex:        IP No: 
I confirm that I have understood the purpose of this study. I have the 
opportunity to clarify my queries and doubts and they have been answered to 
my satisfaction.  
I understand that my parcipation is purely voluntary and I am free to 
withdraw any time without giving reasons  
I have understood that the investigator ,regulatory authorities and the 
ethics committee will have access to my health records both in respect to 
current study and any further research that may be conducted in relation to it 
,even if I decide to withdraw from the study.i have understood that my identity 
will not be revealed in anyway and information related to third parties or 
published ,unless as required under the law. i agree not to restrict the use of any 
data or results that arise from the study.  
Without any compulsion I am willing to give consent for the 
participation of myself  in this study.  
 
DATE:                                                                                                                                                             
PLACE:                                                                                                                                                                                                            
Signature of Patient 
                                                                                                                                                             
Signature of the investigator:  
  
Name of the investigator  
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                                           இ~பt , 
                                                                                              
(ைகெயா~ப) 
 
 
 
 
 
 
 
 
 
no name
       
age parity GA HT WT BMI W/H %
F/H/ 
DM HB RFT LFT HBA1C 1TM 2TM 3TM R.FAC p.e IOL ND LSCS LGA SGA
HYPO. 
GLY BA
HYP 
.BIL B.WT APG
pre. 
preg
till 14 
wks
EP Wt. 
GAIN t.wg
1 bharathi 19 primi 8w3d 153 43 18.4 74 1 11.3 n n 5.05 122 131 155.9 gdm/mp 1 1 0 2/fd 0 0 0 0 0 2.6 8 43 43.5 0.5 50
2 madhudevi 26 g2p1l1 7w4d 153 45 19.2 72 1 9.8 n n 4.8 98 184 122 gdm/mp 0 0 1 0 0 0 1 0 0 3.6 8 45 47.5 2.5 54
3 nancy 27 primi 9w 153 60 25.6 84 1 11.3 n n 5.1 108 152 120 gdm/ins 1 1 0 2/fd 1 0 1 1 0 3.74 7 60 64 4 72
4 muniammal 28 primi 7w6d 157 55 22.3 72 0 11.7 n n 5.3 98 148 140 gdm/mp 0 0 0 2/b.in l 0 0 0 0 0 2.74 8 55 56 1 63
5 parameshwari 27 g3p2l1 8w1d 152 61.5 26.6 70 1 11.4 n n 5.2 102 154 123 gdm/mp 1 0 0 2/cpd 0 0 0 0 1 3.3 8 61.5 63.6 2.1 70
6 vasanthakumari 23 g3p2l1 7w4d 145 45 21.4 72 1 10.7 n n 5.4 84 162 112 gdm/poly 0 0 0 2/prom 0 0 1 0 0 3.24 7 45 46 1 54
7 lavanya 24 primi 8w2d 148 53 24.2 82 1 11 n n 4.8 122 164 104 gdm/mp 0 1 1 0 0 0 0 0 1 2.9 8 53 55.5 2.5 63
8 sumathi 29 g2p1l1 9w3d 160 50 19.5 68 1 9.8 n n 5.1 123 158 112 gdm/mp 0 0 1 0 0 0 0 0 0 2.96 8 50 51 1 59
9 dhanalaxmi 32 g2p1l1 8w6d 154 56 23.6 71 0 8.8 n n 6.0 87 174 82 gdm/mp 1 0 0 2/pls 0 0 0 0 0 3.36 7 56 58.2 2.2 74
10 tamilselvi 32 g2p1l1 9w2d 158 52 20.8 76 1 12 n n 5.2 130 130 152 gdm/mp 1 1 1 0 0 1 0 0 0 2.3 8 52 54.5 2.5 60
11 veronica 28 g2a1 10w 156 47 19.3 69 1 9.5 n n 5.3 73 148 82 gdm/mp 0 0 0 0 0 0 0 0 1 2.92 8 47 48 1 63
12 kalaiarasi 24 primi 11w 158 52 20.8 78 1 11.6 n n 5.6 113 120 167 gdm/ins 1 1 0 2/fi 0 0 1 0 1 2.96 8 52 55 3 61
13 gunasundari 27 g2p1l1   6w2d 156 48 19.7 74 0 11.9 n n 5.8 84 135 106 0 0 0 1 0 0 0 0 0 1 2.76 8 48 48.5 0.5 58
14 kannagi 33 primi 7w4d 160 52 20.3 76 1 10.9 n n 4.7 86 148 114 gdm/mp 0 1 1 0 0 0 0 1 0 2.85 6 52 53 1 61
15 vidhya 25 g3p1l1a1 8w3d 162 58 22.1 84 1 10 n n 5.7 105 162 142 gdm/ins 0 1 1 0 0 0 1 0 0 3.1 8 58 60.2 2.2 69
16 divya 24 primi 9w2d 158 52 20.8 74 1 14.9 n n 5.8 106 144 156 gdm/ins 1 0 0 2/pcs 1 0 1 0 0 3.56 8 52 52.5 0.5 62
17 vedavalli 28 g2p1l1 8w4d 162 51 19.6 76 0 12.3 n n 5.6 124 138 134 0 0 0 1 0 0 0 1 0 0 2.9 8 51 51.5 0.5 62
18 santhana roselin 31 g3p2l2 9w4d 160 58 22.7 78 0 10 n n 5.7 122 176 138 gdm/ins 0 1 0 2/fd 0 0 0 0 1 3.3 8 58 58 0 69
19 arokiamary 33 g2p1l1 7w3d 148 54 24.7 82 1 11.9 n n 5.5 106 141 164 gdm/ins 0 0 0 2/cpd 1 0 0 0 1 3.1 8 54 57 3 64
20 saraswathi 24 primi 8w3d 157 67 27.2 84 1 11 n n 5.2 108 112 150 gdm/mp 1 1 0 2/fd 0 0 0 0 0 2.8 8 67 68.8 1.8 78
21 shanthi 30 primi 9w4d 154 62 26.1 73 1 11.9 n n 5.5 106 178 142 gdm/ins 1 0 0 2/b.baby 1 0 1 0 1 3.8 8 62 64.3 2.3 72
22 manjula 28 g2p1l1 14w3d 151 70 30.7 86 1 12 n n 5.8 134 189 144 gdm/poly 0 0 0 2/fd 1 0 1 0 1 3.6 8 70 74 4 82
23 anandhi 23 g2a1 16w 168 70 24.8 79 1 11.1 n n 5.6 120 147 120 gdm/mp 1 1 1 0 0 1 0 0 1 1.9 7 70 74 4 82
24 muthulaxmi 29 primi 12w 160 52 20.3 68 0 10.6 n n 5.4 86 124 90 0 0 0 1 0 0 0 0 0 0 3 8 52 52.5 0.5 62
25 bhuvaneshwari 29 primi 13w 162 57 21.7 69 0 11 n n 5.3 97 162 98 gdm/poly 0 0 0 2/fd 1 0 0 0 1 3.4 8 57 59.4 2.4 65
26 janet 30 g2p1l1 16w 155 50 20.8 70 1 10 n n 4.8 96 161 145 gdm/ins 1 1 1 0 0 0 0 0 0 3 8 50 52.3 2.3 61
27 kavitha 21 primi 12w 151 60 26.3 69 1 11 n n 5.2 123 142 121 gdm /mp 0 0 0 2/fd 0 0 0 1 0 2.8 8 60 60.5 0.5 70
28 sangeetha 30 primi 14w3d 156 58 23.8 72 0 10.8 n n 5.4 132 122 124 0 0 0 1 0 0 0 0 0 1 2.8 8 58 58.5 0.5 68
29 alamelu 24 primi 12w4d 154 46 19.4 68 1 12 n n 6 124 164 126 gdm/mp 0 1 1 0 0 0 1 0 0 2.6 7 46 47.5 1.5 55
30 shamugapriya 20 primi 13w3d 156 58 23.8 76 1 11 n n 5.4 101 132 128 0 0 0 0 2/fd 0 0 0 1 0 3.37 8 58 58.5 0.5 65
31 padmavathi 21 primi 12w 153 41 17.6 64 0 12 n n 4.8 114 156 124 gdm/mp 0 0 0 2/cpd 0 0 0 0 0 2.56 8 41 43.2 2.2 48
32 sivagami 34 g4p1l1a2 14w3d 150 51 22.7 74 1 11 n n 5.6 103 112 138 0 0 0 0 2/fd 0 0 1 0 0 2.68 9 51 52 1 60
33 kala 25 primi 16w 154 54 22.8 74 1 10.5 n n 5.2 112 156 114 gdm/mp 1 0 1 0 0 0 1 0 1 2.8 7 54 56.3 2.3 60
34 sri kanya sarasu 32 G2P1L1 8w 159 50 19.8 68 0 10 n n 5.8 89 145 132 gdm/mp 0 1 0 2/cpd 0 0 0 0 1 2.9 8 50 53 3 61
35 venda 20 G2P1L1 8w3d 159 59 23.3 72 0 10.4 n n 5.4 108 124 123 0 0 0 1 0 0 0 0 0 1 2.45 8 59 59.5 0.5 67
36 veena 30 G3P1L1A1 7w4d 146 45 21.1 65 1 11 n n 5.7 92 126 152 gdm/mp 1 1 0 2/cpd 0 0 1 0 0 3.1 8 45 47.5 2.5 55
37 udayadeepika 24 primi 11w 172 56 18.9 78 0 9.8 n n 5.6 98 148 126 gdm/mp 0 1 0 2/fd 0 0 0 0 1 3.6 8 56 59 3 65
38 gangadevi 30 primi 12w 140 51 26 68 1 10.2 n n 5.4 102 145 168 gdm/ins 1 1 0 2/fd/bb 1 0 1 0 1 3.67 7 51 54 3 61
39 nirmala 21 G4P3L1A0 10w1d 158 52 20.8 70 1 12 n n 4.8 112 123 156 gdm/mp 0 0 1 0 0 0 0 0 0 2.86 8 52 53 1 61
40 revathy 30 G3P1L1A1 12 160 58 22.7 81 1 11 n n 5.2 102 143 148 gdm/mp 0 1 0 2/cpd 0 0 1 0 1 2.88 8 58 60.3 2.3 67
41 muthumari 27 primi 8w3d 156 52 21.4 73 1 10.3 n n 4.9 86 167 132 gdm/mp 0 0 0 2/fd 0 0 1 1 0 2.5 6 52 52.5 0.5 62
42 sangeetha 24 G3P1L1A1 9w4d 152 86 37.2 90 1 11 n n 5.6 104 192 147 gdm/ins 1 1 0 2/fi 0 0 0 0 1 3.6 8 58 60.5 2.5 80
43 manimegalai 36 G2P1L1 10w1d 158 74 29.6 78 0 12 n n 5.2 88 122 134 0 0 0 0 2/fd 0 0 1 0 0 2.8 8 74 74.5 0.5 85
44 ambika 25 primi 10w3d 160 65 25.4 74 0 12 n n 5.4 124 166 126 gdm/mp 0 0 1 0 0 0 0 0 1 2.7 8 65 67.2 2.2 75
45 suganya 32 G2P1L1 11w2d 158 60 24 72 1 10.6 n n 5.6 112 158 132 gdm/poly 1 0 0 2/cpd 0 0 0 1 0 2.8 8 60 62.5 2.5 70
46 muthulaxmi 32 G3P1L1A1 11w4d 162 58 22.1 78 1 9.8 n n 5.4 130 178 124 gdm/ins 0 1 0 2/fd 0 0 1 0 1 3.4 8 58 59.5 1.5 68
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47 selvi 25 primi 8w3d 151 54 23.8 70 1 10.3 n n 5.2 124 148 156 gdm/mp 0 1 0 2/fd 0 0 0 0 1 3.2 8 54 56.2 2.2 65
48 deepa 30 primi 9w3d 152 50 21.6 76 1 11 n n 5.3 78 156 123 gdm/mp 0 0 1 0 0 0 1 1 0 3.5 7 50 51 1 61
49 sangeetha 35 primi 7w4d 156 52 21.4 77 1 10.2 n n 4.9 98 168 128 gdm/mp 1 1 0 2/fi 0 0 0 0 0 3.4 8 52 54.8 2.8 62
50 sudha 19 primi 8w4d 153 45 19.2 76 1 10.6 n n 5 132 158 146 gdm/ins 0 0 1 0 0 0 1 0 1 3 8 45 47.5 2.5 55
51 krishnaveni 29 G3P1L1A1 8w4d 154 60 25.3 72 0 12 n n 5.3 124 120 124 0 0 1 0 2/fd 0 0 1 0 0 2.9 8 60 61.5 1.5 70
52 bhuvaneshwari 29 G3P1L1A1 9w2d 148 44 20.1 69 1 10.2 n n 5.3 132 146 145 gdm/mp 0 1 0 2/fd 0 0 0 0 0 2.8 8 44 45.7 1.7 55
53 lavanya 27 G3P1L1A1 8w4d 153 48.5 20.7 70 1 9.6 n n 6 88 156 123 gdm/mp 0 1 1 0 0 0 1 0 1 2.6 8 48.5 49 0.5 56
54 vijayalaxmi 28 primi 9w3d 148 60 27.6 72 0 11 n n 5.2 106 152 124 gdm/mp 1 0 0 2/fd 0 0 1 0 0 2.6 8 60 61.7 1.7 70
55 sakila 28 primi 10w4d 166 83 30.1 82 1 12 n n 5.8 98 197 152 gdm/ins 0 0 1 0 1 0 1 0 0 3.62 7 83 86 3 92
56 laxmi 29 primi 11w2d 158 50 20 75 1 11.2 n n 5.4 86 156 146 gdm/ins 1 1 0 2/fi 0 0 1 0 1 3.2 8 50 52.5 2.5 62
57 stellamary 21 primi 10w3d 161 50 19.3 76 1 12 n n 5.3 124 134 167 gdm/ins 0 0 1 0 0 0 0 0 0 3.1 8 50 51 1 60
58 bhuvaneshwari 29 G2P1L1 12w 155 72 30 75 0 11 n n 5.4 132 112 126 0 0 1 1 0 0 0 0 0 1 2.9 8 72 71.5 -0.5 80
59 amudhavalli 24 primi 12w4d 156 54 22.2 72 0 11 n n 5.5 128 199 178 gdm/ins 0 1 0 2/fd 0 0 1 0 0 3.5 8 54 57.5 3.5 61
60 anandhi 23 G2A1 13w6d 153 53 22.6 78 1 10.6 n n 5.3 124 163 145 gdm/mp 0 0 1 0 0 0 1 0 0 1.9 8 56 58.4 2.4 65
61 sulochanapriya 27 g2p1l1 14w3d 156 54 22.2 75 1 11.2 n n 2 124 192 138 gdm/ins 0 1 0 2/fd 0 0 0 0 0 3.2 9 56 57.5 1.5 66
62 selvi 28 g3p1l1a1 15w 162 68 25.9 76 0 10.3 n n 4.8 122 156 142 gdm/mp 0 0 0 2/fd 0 0 0 0 1 2.88 7 68 69.7 1.7 75
63 padmavathi 24 primi 14w 154 63 26.6 74 1 9.8 n n 5 123 192 124 gdm/ins 0 1 0 2/c.pp 0 0 1 0 0 2.43 7 58 57 -1 67
64 subha 25 primi 12w3d 152 53 22.9 72 1 10.1 n n 5 118 154 126 gdm/ins 0 1 1 0 0 0 1 0 0 3.29 9 52 54.5 2.5 63
65 jency 25 primi 13w3d 168 73 25.9 81 0 10.3 n n 5.7 123 134 158 gdm/poly 0 0 0 2/cpd 0 0 0 0 1 3.33 8 54 56.5 2.5 65
66 parimala 27 g2p1l1 14w2d 157 54 21.9 76 1 12 n n 5.5 133 156 124 gdm/mp 1 0 1 0 0 0 0 0 0 2.75 7 57 59.7 2.7 66
67 abithabee 37 g3p1l1a1 12w4d 156 56 23 80 1 11.3 n n 5.3 123 120 155 gdm/mp 0 1 0 2/fi 0 1 0 0 0 2.3 8 58 58 0 67
68 mahalaxmi 27 g2p1l1 16w 153 57 24.3 83 0 10.8 n n 5.2 124 126 172 gdm/mp 0 1 1 0 0 0 0 0 0 2.9 7 56 58.6 2.6 66
69 manjula 33 g2p1l1 14w 154 52 21.9 76 1 10 n n 5.1 126 135 167 gdm/mp 0 0 0 2/fd 0 0 0 1 0 2.96 8 54 53 -1 62
70 jayalaxmi 22 primi 12w 153 51 21.8 78 1 10.2 n n 5.4 121 153 138 gdm/mp 0 1 1 0 0 0 0 0 1 2.7 8 52 54.5 2.5 62
71 jagadeeswari 19 primi 11w2d 156 52 21.4 62 0 11 n n 5.4 127 156 123 gdm/mp 0 0 0 2/fd 0 0 0 0 1 2.97 8 53 53.5 0.5 61
72 ilavarasi 35 e.primi 9w3d 153 49 20.9 65 1 10.8 n n 5.6 112 156 138 gdm/mp 0 1 0 2/fi 0 0 1 0 0 2.4 8 49 51.3 2.3 59
73 vasanthi 24 primi 10w4d 158 53 21.2 70 0 9.8 n n 5.2 145 158 140 gdm/ins 0 1 1 0 0 0 0 0 1 2.7 7 51 52.5 1.5 61
74 sangeetha 28 primi 10w1d 154 60 25.3 72 1 10.1 n n 5.1 123 156 138 gdm/mp 0 0 1 0 0 0 0 0 0 3 8 60 61.8 1.8 71
75 jagadeeswari 33 g2p1l1 9w3d 150 52 23.1 71 0 11 n n 5.6 148 132 138 gdm/mp 0 0 0 2/cpd 0 0 0 0 0 2.3 8 52 51 -1 61
76 sakila 33 primi 9w4d 152 54 23.4 73 1 11 n n 5.4 124 156 132 gdm/mp 1 1 0 2/fd 0 0 1 0 1 2.5 8 52 54.4 2.4 64
77 vijayalaxmi 29 g3p1l0 9w6d 156 52 21.4 74 0 10 n n 5.2 123 168 142 gdm/ins 0 0 0 2/cpd 0 0 1 0 1 2.5 7 52 52.5 0.5 62
78 sangeetha 23 g2p1l1 10 157 54 21.9 75 1 9.8 n n 5.1 122 146 141 gdm/poly 0 0 1 0 0 0 0 0 0 2.8 7 54 56.2 2.2 63
79 vasanthalaxmi 29 primi 10w2d 154 48 20.2 69 0 10.1 n n 4.9 124 152 132 gdm/mp 0 1 0 2/fi 0 0 1 0 0 3.23 8 52 54.5 2.5 58
80 vijayalaxmi 23 primi 8w4d 156 52 21.4 74 1 11.1 n n 4.8 126 148 136 gdm/ins 0 1 0 2/fd 0 0 0 0 0 3.04 7 52 52.5 0.5 62
81 anandhi 23 g2a1 7w4d 152 48 20.8 73 0 10.2 n n 4.3 124 112 136 0 0 0 1 0 0 1 1 0 1 1.9 8 48 49 1 52
82 shobana 25 primi 8w3d 148 46 21 71 1 11.2 n n 4.5 122 164 144 gdm/mp 0 0 0 2/fi 1 0 1 0 0 3.5 8 46 48.5 2.5 57
83 shakila 37 primi 9w4d 153 45 19.2 68 0 10.8 n n 5.3 132 167 145 gdm/ins 0 0 1 0 0 0 0 0 1 2.9 7 45 47.2 2.2 57
84 shanawaz 28 g3p2l2 8w2d 156 53 21.8 70 1 11.2 n n 5.4 123 156 138 gdm/ins 0 1 0 2/pcs 0 0 0 0 0 3.1 8 53 54 1 62
85 nithya 27 primi 8w4d 158 54 21.6 71 0 11 n n 5.2 122 158 123 gdm/mp 0 0 0 2/oligo 0 0 0 1 0 2.2 8 52 54.5 2.5 64
86 saraswathy 42 g4p2l0a1 8w2d 154 52 21.9 74 0 12 n n 5.1 123 124 134 0 0 0 0 2/pcs 0 1 1 1 1 1.7 7 52 53 1 61
87 ilavarasi 35 primi 9w3d 148 52 23.7 80.5 0 11 n n 5.5 112 154 123 gdm/mp 0 1 0 2/fi 0 0 0 0 0 2.4 8 52 52 0 63
88 vasanthi 24 primi 7w4d 150 48 21.3 74 1 10.2 n n 5.3 108 167 142 gdm/ins 0 0 1 0 0 0 0 0 0 2.7 7 48 50.5 2.5 58
89 bhavani 28 primi 8w4d 148 54 24.7 81 0 10 n n 5.2 110 156 138 0 0 1 0 2/fi 0 1 0 0 0 2.2 8 54 54.5 0.5 64
90 deepa 26 primi 9w 156 54 22.2 74 1 11 n n 4.9 110 114 156 gdm/ins 0 1 0 2/fd 0 0 0 0 0 3.29 8 54 54.5 0.5 63
91 pavithra 27 primi 8w4d 149 45 20.3 69 1 10.1 n n 4.8 108 152 124 gdm/mp 0 0 0 2/fd 0 0 0 0 0 2.66 8 45 47.4 2.4 56
92 saraswathi 32 g2p1l1 9w1d 152 49 21.2 70 0 9.8 n n 5.1 110 132 122 0 0 1 1 0 0 0 0 0 1 2.8 8 49 49.5 0.5 58
93 kavitha 31 g2p1l0 10w 154 51 21.5 72 1 10.2 n n 5.4 108 152 124 gdm/ins 0 0 0 2/fi 0 0 0 0 0 3 7 51 52 1 54
104
94 divya 24 primi 6w1d 152 50 21.6 73 0 11 n n 5.3 124 112 134 0 0 0 0 2/fd 0 0 0 1 1 3.3 8 50 52.2 2.2 62
95 lavanya 24 primi 6w5d 148 42 19.2 67 0 10 n n 5.6 112 154 132 gdm/ins 0 1 1 0 0 0 0 0 1 2.6 7 42 43 1 53
96 sumathi 28 g2p1l1 7w2d 154 49 20.7 64 1 10.2 n n 5.2 104 134 146 gdm/mp 0 0 0 2/cpd 0 0 1 0 0 2.9 8 49 49 0 56
97 kanniga 28 g2p1l1 7w4d 147 49 22.7 76 1 10.4 n n 5.4 109 132 148 gdm/mp 0 1 1 0 0 0 0 0 1 3.29 8 49 51.3 2.3 60
98 tamilselvi 25 g3p2l2 7w2d 156 52 21.4 75 0 11 n n 5.3 110 123 110 0 0 0 0 2/fd 0 0 1 0 0 2.3 7 52 52.5 0.5 62
99 indumathi 25 g2p1l1 7w3d 153 51 21.8 72 0 10.2 n n 5.2 106 152 116 gdm/ins 0 0 0 2/fd 0 0 0 0 0 3.1 8 52 52.5 0.5 65
100 nithya 32 g2p1l1 8w3d 152 48 20.8 74 0 10 n n 5.1 108 145 152 gdm/mp 0 0 0 2/pcs 0 0 0 1 0 2.68 7 54 54.5 0.5 58
101 sakthi sangeetha 27 primi 6w4d 148 45 20.5 68 1 9.8 n n 5.5 118 154 108 gdm/mp 0 1 1 0 0 0 0 0 1 3 7 45 47.5 2.5 58
102 amudhalavanya 30 primi 7w2d 152 58 25.1 82 0 11.6 n n 5.2 102 124 156 gdm/mp 0 0 0 2/fi 1 0 1 1 0 3.7 8 58 60.5 2.5 67
103 lalitha 29 g3p2l2 8w 149 52 23.4 81 1 10.6 n n 5.3 106 156 123 gdm/mp 0 1 1 0 0 0 1 0 1 2.3 8 52 54.5 2.5 62
104 vijayalaxmi 26 primi 7w2d 150 53 23.6 80.5 0 10.2 n n 4.9 107 148 124 gdm/mp 0 0 0 2/fd 0 0 0 0 0 3 8 54 55 1 58
105 rajeswari 30 g2p1l1 8w2d 154 51 21.5 81 0 11.2 n n 5.4 116 116 148 gdm/mp 1 1 0 2/fd 0 0 1 0 1 3.3 8 51 52.8 1.8 61
106 geethaumachandar 29 g2p1l1 7w2d 153 49 20.9 74 0 12 n n 4 120 152 124 gdm/mp 0 0 0 2/fd 0 0 0 0 0 3.25 7 49 51.5 2.5 59
107 logeshwari 25 g2p1l1 8w 147 52 24.1 84 1 13 n n 5.6 103 156 120 gdm/mp 1 1 1 0 0 0 0 0 0 2.6 8 52 54.3 2.3 62
108 dillidevi 25 primi 7w3d 152 51 22.1 80 0 11 n n 5.7 112 124 123 0 0 1 0 2/fd 0 0 0 0 1 2.9 8 51 51.5 0.5 61
109 sulochana 31 primi 7w3d 151 49 21.5 79 0 12 n n 5.8 124 156 134 gdm/mp 0 0 0 2/fd 0 0 1 0 1 2.5 8 49 51.6 2.6 58
110 shabeen 24 g3p2l2 7w4d 149 54 24.3 82 0 10.6 n n 6 108 124 138 0 0 1 0 2/fi 0 0 0 0 0 2.6 8 54 54.5 0.5 64
111 mary 29 g2a1 6w4d 153 64 27.3 85 0 10.1 n n 6 110 174 145 gdm/ins 0 1 1 0 1 0 1 0 0 3.6 8 64 67 3 78
112 radha 30 g2p1l1 7w 156 53 21.8 73 0 10.2 n n 5 102 134 172 gdm/mp 0 0 0 2/fd 0 0 0 0 0 2.6 8 53 54 1 64
113 meena 28 g2p1l1 8w2d 153 50 21.4 76 1 10.5 n n 5.6 112 162 124 gdm/mp 0 1 1 0 0 0 0 0 1 2.75 8 50 52.6 2.6 58
114 santhanalaxmi 37 primi 7w4d 162 58 22.1 74 0 11 n n 5.4 103 176 146 gdm/ins 0 0 1 2/fd 0 0 1 0 0 2.75 8 58 58.5 0.5 67
115 yasodha 27 primi 7w6d 149 50 22.5 71 0 12 n n 5.5 111 154 146 gdm/ins 1 1 1 0 0 0 0 1 0 3.09 8 50 53 3 59
116 bhavani 26 g2p1l0 8w 150 48 21.3 70 0 11.4 n n 5 106 124 123 0 0 0 1 0 0 0 0 0 0 3 8 48 48.5 0.5 58
117 laxmi 32 g2p1l1 8w1d 152 47 20.3 69 1 10.2 n n 5.4 109 142 157 gdm/ins 0 0 0 2/fd 1 0 1 0 1 4.1 6 47 49.5 2.5 60
118 tenmozhi 24 g2p1l0 10w3d 156 65 26.7 83 1 9.9 n n 5.3 138 154 146 gdm/mp 0 1 1 0 1 0 1 0 0 3.63 8 65 67.3 2.3 75
119 deepa 26 primi 10w2d 153 64 27.3 86 1 10.4 n n 5.2 118 156 128 gdm/ins 0 1 0 2/fi 0 0 0 0 0 3.2 8 62 64.5 2.5 66
120 hefsiba 35 g3p2l2 11w 152 56 24.2 81 1 10.2 n n 5.6 118 123 134 0 0 0 0 2/pcs 0 0 0 0 0 3.2 8 54 56.5 2.5 58
121 sumithradevi 25 primi 10w 158 72 28.8 84 0 12 n n 5.4 120 120 178 gdm/ins 0 0 0 2/fd 1 0 1 0 1 4 8 72 74.5 2.5 84
122 amirtham 35 primi 6w4d 149 43 19.4 68 0 11 n n 5.2 98 110 146 gdnm/mp 0 1 1 0 0 0 1 0 0 3.2 8 43 45.3 2.3 54
123 athilaxmi 26 g3p1l1a1 7w1d 152 49 21.2 78 0 10.2 n n 4.9 124 112 153 gdm/mp 0 0 1 0 0 0 0 0 0 3 8 49 51.5 2.5 59
124 maryrubina 24 primi 12w4d 156 63 25.9 80.5 1 10.2 n n 4.3 118 146 126 gdm/mp 0 1 0 2/fd 0 0 1 0 1 3.1 8 44 46.2 2.2 53
125 sangeetha 24 g2p1l1 13w 157 52 21.1 69 0 9.8 n n 4.8 120 132 124 0 0 0 0 2/cd 0 0 0 0 0 3.17 8 52 53 1 63
126 kavitha 23 primi 9w 158 56 22.4 71 0 10.6 n n 4.9 117 124 123 0 1 0 0 2/cpd 0 0 0 0 0 2.8 8 56 55 -1 66
127 parvathy 30 primi 10w 158 52 20.8 72 0 11.2 n n 4.9 124 112 108 0 0 0 1 0 0 0 0 0 1 3.2 8 52 51 -1 63
128 punitha 28 g3p1l1a1 11w 156 42 17.3 64 0 10.8 n n 5.3 122 110 124 0 0 0 1 0 0 0 0 0 0 2.8 7 45 45 0 55
129 priya 23 g2p1l1 9w 162 56 21.3 71 0 11 n n 5.4 120 121 120 0 0 0 1 0 0 0 0 0 0 2.8 8 56 57 1 66
130 ananthi 23 primi 12w 157 51 20.7 76 0 11.6 n n 5.8 116 108 112 0 0 0 1 0 0 1 0 0 0 1.9 7 51 50 -1 60
131 bhuvaneshwari 28 g2a1 8w2d 148 52 23.7 74 1 10.4 n n 5.3 114 110 122 0 1 0 1 0 0 0 0 0 0 3.4 8 52 54.2 2.2 62
132 saritha 22 primi 9w4d 157 48 19.5 68 0 11 n n 5 122 106 120 0 0 0 1 0 0 0 0 0 1 2.8 8 48 48 0 58
133 vidhubala 31 primi 8w2d 152 48 20.8 67 0 11.2 n n 5.7 120 112 117 0 0 0 0 2/fd 0 0 0 0 0 2.8 7 48 47 -1 58
134 bhuvaneshwari 23 g2p1l1 10w2d 164 54 20.1 70 0 12 n n 5 130 126 124 0 1 0 1 0 0 0 0 0 1 3.4 8 54 58.5 4.5 64
135 revathy 22 g2a1 11w 158 52 20.8 71 0 9.6 n n 5.2 124 122 120 0 0 0 1 0 0 0 0 0 0 2.7 6 52 50.5 -1.5 63
136 umamaheswari 30 g2p1l1 9w 166 58 21 74 1 10 n n 5.5 132 124 118 0 0 0 0 2/fi/bb 1 0 0 0 1 3.9 7 58 60.4 2.4 67
137 poongavanam 29 g2p1l1 10w 156 52 21.4 78 0 10.2 n n 5.2 122 132 124 0 0 0 0 2/pcs 0 0 0 0 0 2.8 7 56 55 -1 66
138 gomathy 23 primi 9w3d 160 58 22.7 74 0 11 n n 5.1 116 126 116 0 0 0 1 0 0 0 0 0 0 3.2 7 58 57 -1 68
139 vatchala 29 g2p1l1 10w 156 54 22.2 75 0 12 n n 4.9 124 122 114 0 0 0 1 0 0 0 0 0 0 2.79 7 52 54.3 2.3 64
140 valli 30 g2p1l1 9w3d 158 54 21.6 68 0 11.6 n n 5 130 124 118 0 0 1 1 0 0 0 0 0 0 2.75 8 52 51 -1 62
105
141 janet 30 primi 8w6d 157 50 20.3 68 0 13 n n 5.1 114 122 116 0 0 0 1 0 0 0 0 0 0 3.1 8 50 49 -1 60
142 aruna 32 g3p1l1a1 9w 152 56 24.2 77 0 11 n n 5.2 118 112 114 0 0 0 0 2/pcs 1 0 0 0 1 3.9 8 56 58.5 2.5 66
143 ananthi 26 primi 9w2d 156 52 21.4 75 0 10.8 n n 5 112 129 122 0 0 0 0 2/fpd 0 0 0 1 1 3.4 8 52 51 -1 63
144 gunasundari 21 g2a1 9w5d 154 51 21.5 73 0 9.9 n n 5.1 116 116 114 0 0 0 0 2/fd 0 0 0 0 0 3 6 51 53.3 2.3 59
145 kalaivani 21 primi 10w3d 149 50 22.5 74 0 10.1 n n 4.9 114 98 107 0 0 0 1 0 0 0 0 0 0 2.8 7 50 49 -1 60
146 umamaheswari 28 g2p1l1 8w2d 154 48 20.2 69 0 10 n n 5.3 123 124 128 0 0 0 1 0 0 0 0 0 0 2.4 8 48 48.5 0.5 57
147 kalpana 28 primi 9w 158 52 20.8 70 0 10.1 n n 5.1 130 122 125 0 1 0 1 0 0 0 0 0 1 2.3 7 52 54.5 2.5 62
148 raziaamin 25 g2a1 9w3d 164 58 21.6 76 1 10.6 n n 4.9 117 123 117 0 0 0 0 2/fi 0 0 0 0 0 2.8 7 58 57 -1 69
149 julieparveen 24 g3p2l1 10w1d 162 53 20.2 72 0 10.8 n n 4.8 122 124 126 0 0 0 1 0 0 0 0 0 1 3.5 8 53 52.5 -0.5 62
150 suguna 29 primi 10w2d 160 54 21.1 73 0 11 n n 4.9 110 116 108 0 0 0 0 2/fd 0 0 0 0 0 3.8 8 54 56.2 2.2 65
151 lilly 29 g2p1l1 11w 156 51 21 69 0 10.5 n n 5.1 107 116 118 0 0 1 1 0 0 0 0 0 0 3.3 8 58 57 -1 68
152 vijayalaxmi 22 primi 11w3d 152 56 24.2 81 0 9.9 n n 5.2 114 112 115 0 0 0 1 0 0 0 0 0 0 2.8 7 56 56.5 0.5 66
153 bhuvaneshwari 27 g2p1l1 8w5d 154 49 20.7 69 0 10.1 n n 5.4 114 124 122 0 0 0 1 0 0 0 0 0 1 3.2 8 49 48 -1 58
154 ananthi 35 g3p1l1a1 9w 158 52 20.8 68 0 10.4 n n 5.4 104 128 124 0 0 0 1 0 0 0 0 0 0 2.8 7 52 50.5 -1.5 62
155 vinodhini 28 primi 10w2d 149 48 21.6 70 0 10.2 n n 5.3 102 106 114 0 0 0 0 2/fi 0 0 0 1 0 3.3 8 48 50.5 2.5 58
156 devi 25 primi 9w3d 150 50 22.2 71 0 11.4 n n 5.1 108 112 124 0 0 0 1 0 0 0 0 0 0 2.3 7 50 49 -1 61
157 laxmi 23 g2p1l1 8w4d 152 51 22.1 76 0 9.9 n n 5.2 112 123 130 0 0 0 1 2/fd 0 0 0 0 0 2.34 8 51 53.4 2.4 61
158 durgadevi 28 primi 9w4d 156 52 21.4 75 0 10.6 n n 5.5 102 116 124 0 0 0 0 0 0 0 0 0 1 3.1 8 52 52.5 0.5 63
159 devika 24 primi 10w 154 51 21.5 73 0 10.4 n n 5.2 108 114 126 0 1 0 0 2/fd 0 0 0 0 0 2.8 7 51 53.6 2.6 63
160 abitha 25 g2p1l1 8w3d 151 49 21.5 72 0 10.1 n n 5.4 112 112 123 0 0 0 0 2/fd 0 0 0 0 0 2.8 8 49 50 1 59
161 santhiya 24 primi 9w 154 52 21.9 75 0 9.8 n n 6 108 124 126 0 0 0 0 2/fd 0 0 0 0 1 3 8 52 51.5 -0.5 62
162 vanitha 31 g3p1l1a1 9w3d 156 54 22.2 73 0 10.2 n n 6.1 112 123 122 0 0 0 1 0 0 0 0 0 0 2.7 7 55 54 -1 65
163 jayapradha 23 g2p1l1 10w3d 158 53 21.2 74 0 12 n n 5.3 98 113 108 0 0 1 1 0 0 0 1 0 1 3.5 8 53 56.4 3.4 62
164 vijayalaxmi 27 g2p1l1 9w6d 153 51 21.8 76 0 11.1 n n 5.2 100 114 109 0 0 1 1 0 0 0 0 0 0 3.1 8 51 51.5 0.5 61
165 bhuvaneshwari 30 g3p1l1a1 8w3d 152 50 21.6 75 0 10.3 n n 5.1 101 123 105 0 0 0 1 0 0 0 0 0 0 3 7 52 51.5 -0.5 62
166 kavitha 25 g2p1l1 9w 152 49 21.2 76 1 11 n n 5.8 108 126 108 0 0 0 1 0 0 0 0 0 1 2.9 8 49 51.5 2.5 59
167 thenmozhi 20 primi 9w1d 149 48 21.6 77 0 10.2 n n 5.4 112 118 104 0 0 0 1 0 0 0 0 0 0 2.7 7 48 49 1 58
168 vinitha 37 g2p1l1 10w 156 52 21.4 78 0 9.9 n n 5.3 96 114 118 0 0 0 1 0 0 0 0 0 0 3 8 49 50 1 59
169 malini 31 g3p1l1a1 10w1d 150 48 21.3 76 0 10 n n 5.2 113 112 105 0 0 0 0 2/fd 0 0 0 0 0 3.25 8 48 51 3 57
170 arputhamani 21 primi 11w 154 54 22.8 72 0 11.2 n n 5.1 108 111 116 0 0 0 1 0 0 0 0 0 0 3.1 6 54 54.5 0.5 64
171 megala 23 primi 9w 156 53 21.8 76 0 10.2 n n 4.8 112 98 106 0 0 0 1 0 0 0 0 0 0 2.5 7 53 55.2 2.2 63
172 divya 23 g2p1l1 9w1d 150 51 22.7 73 0 9.8 n n 4.9 108 106 105 0 0 1 1 2/fd 0 0 0 1 1 3.165 7 52 52.5 0.5 63
173 rekha 30 primi 8w2d 153 50 21.4 74 0 10 n n 4.2 109 112 108 0 0 0 1 0 0 0 0 0 0 3.3 8 50 53 3 60
174 prema 27 primi 8w3d 163 62 23.3 72 0 10.1 n n 4.5 112 108 112 0 0 1 1 0 0 0 0 0 0 2.9 9 62 60 -2 71
175 sasikala 24 g2p1l1 9w 158 54 21.6 69 0 10.6 n n 4.7 108 114 112 0 1 0 1 0 0 0 0 0 0 2.8 9 54 52.5 -1.5 65
176 anitha 22 primi 7w6d 152 51 22.1 77 0 9.8 n n 4.8 112 96 108 0 0 0 0 2/fd 0 0 0 0 0 3.2 8 51 53.7 2.7 62
177 sangeetha 28 primi 8w1d 154 52 21.9 69 1 10.2 n n 4.7 108 101 116 0 0 1 0 0 0 0 0 0 2.87 8 51 50 -1 61
178 gowthami 26 g2p1l1 8w6d 154 54 22.8 70 0 10 n n 5 112 112 107 0 0 0 1 0 0 0 0 0 0 2.7 9 54 53 -1 65
179 janagavalli 28 g2p1l1 7w5d 152 52 22.5 72 0 12 n n 5.1 106 114 108 0 0 1 0 2/pcs 0 0 0 0 0 3.4 8 52 54.5 2.5 62
180 nandhini 23 primi 8w1d 151 48 21.1 69 0 11 n n 5.2 113 109 104 0 0 0 1 0 0 0 0 0 0 2.4 7 48 48.5 0.5 58
181 kalpana 26 g2p1l1 8w4d 154 52 21.9 77 0 10.3 n n 5.3 99 132 124 0 0 0 0 2/cpd 0 0 0 0 0 3.08 8 52 51 -1 61
182 mohanavalli 23 primi 9w6d 153 51 21.8 74 0 10 n n 5.4 98 128 122 0 0 0 1 0 0 0 0 0 0 2.57 8 51 50 -1 59
183 chitra 26 g2p1l1 10w 154 52 21.9 72 0 10.1 n n 5.5 101 124 126 0 0 0 1 0 0 0 0 0 1 3.03 8 52 54.2 2.2 62
184 sudha 27 g2p1l1 8w3d 151 49 21.5 74 1 11 n n 5.3 106 122 108 0 0 0 0 2/fd 0 0 0 0 0 2.8 7 49 49.5 0.5 59
185 selvi 25 g2p1l1 9w 153 50 21.4 76 0 9.9 n n 5.2 112 118 108 0 0 0 0 2/pcs 0 0 0 0 0 3.4 7 51 51.5 0.5 60
186 hemalatha 24 primi 9w1d 156 54 22.2 75 0 10.1 n n 5.1 118 106 108 0 0 1 1 0 0 0 0 0 0 2.39 8 54 53.5 -0.5 64
187 indhuja 25 primi 9w1d 153 51 21.8 73 0 10.4 n n 5.4 107 114 108 0 0 0 1 0 0 0 0 0 0 2.9 8 52 54.3 2.3 63
106
188 nalini 28 g2p1l1 10w 154 52 21.9 72 1 10 n n 5.3 123 112 108 0 0 0 0 2/fd 0 0 0 0 0 2.4 8 52 52.5 0.5 63
189 revathy 24 primi 9w4d 150 48 21.3 74 0 11 n n 5.2 98 118 123 0 0 0 1 0 0 0 0 0 0 3.35 7 48 47 -1 58
190 sarasu 25 primi 10w2d 154 52 21.9 71 0 12 n n 5.1 84 116 106 0 0 0 0 0 0 0 0 1 1 3.24 9 52 51.5 -0.5 61
191 latha 25 g3p1l1a1 11w2d 156 54 22.2 76 0 11.5 n n 5.3 98 112 109 0 0 0 1 0 1 0 0 0 0 3.57 8 54 54.5 0.5 63
192 geetha 27 primi 10w3d 158 56 22.4 74 0 10.8 n n 5.2 112 108 110 0 0 0 0 2/pcs 1 0 0 0 0 3.58 7 54 56.6 2.6 65
193 anjalai 23 g2p1l1 10w 153 49 20.9 74 0 10.2 n n 5.1 102 118 109 0 0 0 1 0 0 0 0 0 0 2.8 7 49 49.5 0.5 58
194 amdha 24 primi 10w1d 155 51 21.2 65 0 9.8 n n 4.9 108 109 110 0 0 0 1 0 0 1 0 0 0 2.18 8 48 48.5 0.5 58
195 marysandhya 25 g2p1l1 9w6d 154 49 20.7 68 0 9.6 n n 4.9 97 101 123 0 0 1 0 2/fi 0 0 0 0 0 2.5 8 49 51.2 2.2 59
196 banu 31 primi 10w2d 156 52 21.4 77 0 10.6 n n 5.2 98 112 103 0 0 0 1 0 0 0 0 0 0 3.38 8 52 51 -1 62
197 muthumari 22 primi 10w3d 154 51 21.5 75 0 10.2 n n 5.3 99 108 106 0 0 0 1 0 0 0 0 0 0 2.91 8 52 51.5 -0.5 63
198 nithya 23 primi 11w 156 53 21.8 75 0 10 n n 5.5 101 112 124 0 0 0 1 0 0 0 0 0 0 2.54 7 54 53.5 -0.5 64
199 alamelu 24 g2p1l1 9w4d 148 43 19.6 74 0 10.1 n n 6 102 114 127 0 0 0 1 0 0 0 0 0 0 2.9 8 53 54 1 63
200 selvameena 25 g2a1 8w35d 140 58 29.6 76 0 12 n n 6.1 120 116 132 0 0 0 0 2/fd 0 1 0 1 1 1.7 7 58 57 -1 68
201 rosy 26 primi 9w3d 146 50 23.5 73 0 11.1 n n 5.8 101 120 124 0 0 1 0 2/fi 0 0 0 0 0 2.3 7 50 52.1 2.1 60
202 laxmi 25 primi 8w2d 148 51 23.3 75 0 10.6 n n 6.2 99 128 126 0 0 0 1 0 0 0 0 0 0 2.8 8 48 49 1 59
203 manjula 19 g2a1 10w 152 48 20.8 76 0 9.9 n n 4.8 88 122 124 0 0 0 1 0 0 0 0 0 0 2.7 8 48 47 -1 58
204 thennarasi 24 primi 9w1d 154 52 21.9 77 0 10.1 n n 4.9 96 123 116 0 0 0 1 0 0 0 0 0 0 2.3 7 52 51 -1 62
205 sangeetha 28 primi 9w4d 154 60 25.3 84 0 9.6 n n 5.2 102 112 118 0 0 0 1 0 0 0 0 0 1 3 8 60 59 -1 70
206 pooja 19 primi 8w6d 150 52 23.1 81 0 10.2 n n 5.3 120 113 115 0 0 1 0 2/fd 0 0 0 0 0 2.5 8 52 51.5 -0.5 61
207 shyamala 24 primi 9w1d 152 51 22.1 76 0 11 n n 5.2 123 114 120 0 0 0 1 0 0 0 0 0 1 2.6 8 51 50 -1 61
208 indira 29 primi 9w3d 154 52 21.9 73 0 10.3 n n 5.7 102 114 116 0 0 0 1 0 0 0 0 0 0 2.5 8 52 51.5 -0.5 56
209 radha 24 g3p1l1a1 10w 148 46 21 75 0 11 n n 5.4 106 108 112 0 0 1 1 0 0 0 0 0 0 2.8 7 48 48.5 0.5 57
210 kaleeshwari 25 g2p1l1 7w3d 150 49 21.8 75 0 10.2 n n 5 104 112 114 0 0 0 0 2/cpd 1 0 1 0 0 3.9 8 49 50 1 61
211 kanagasundari 24 g3p1l1a1 8w1d 163 49 18.4 73 0 11 n n 6 112 108 112 0 0 0 1 0 0 0 0 0 0 2.5 8 49 48 -1 60
212 logeshwari 28 primi 9w1d 147 49 22.7 75 0 11.2 n n 6.1 102 116 120 0 0 0 1 0 0 0 0 0 0 2.7 7 49 48.5 -0.5 59
213 nadhiya 24 primi 8w2d 148 48 21.9 76 0 11.6 n n 6.2 101 126 118 0 0 0 0 2/fd 0 0 0 0 0 2.7 8 48 50.4 2.4 57
214 shanmugapriya 27 g3p1l1a1 9w 161 54 21 74 0 10.8 n n 5.4 112 122 114 0 0 0 0 2/fd 0 0 0 0 0 2.3 7 54 53 -1 63
215 akiladevi 24 g3p1l1a1 9w2d 156 58 23.8 73 0 11 n n 5.2 124 118 120 0 0 1 1 0 0 0 0 0 0 2.2 7 58 57 -1 68
216 sivaranjani 27 primi 8w6d 152 52 22.5 77 0 10.2 n n 5.4 109 106 112 0 0 1 0 2/fi 1 0 0 0 0 3.6 8 52 52.5 0.5 64
217 nithiya 23 primi 9w 154 51 21.5 74 0 10 n n 5.3 124 114 118 0 0 1 1 2/fd 0 0 0 0 0 2.4 7 52 51 -1 63
218 sathya 22 g3p1l1a1 8w3d 156 54 22.2 72 1 11.2 n n 4.5 104 118 108 0 0 0 1 0 0 0 0 0 0 2.7 8 54 53 -1 64
219 shanthi 23 g2p1l1 9w1d 149 43 19.4 68 0 10.8 n n 4.6 112 106 118 0 0 0 1 0 0 0 0 0 0 2.7 8 43 42 -1 52
220 prabha 28 primi 7w3d 152 49 21.2 70 0 10.2 n n 5.1 101 123 106 0 0 0 1 0 0 0 0 0 0 3.1 8 49 49.5 0.5 58
221 mahalaxmi 33 g3p1l1a1 8w 148 50 22.8 72 0 12 n n 5.4 111 121 117 0 0 0 0 2/nopl 0 0 0 0 0 3.4 7 50 51.5 1.5 59
222 celinemary 27 primi 8w2d 150 51.5 22.9 73 0 11.2 n n 5.3 106 112 118 0 0 0 1 0 0 0 0 0 1 2.76 8 51.6 52 0.4 59
223 premalatha 30 g2p1l1 9w1d 152 50 21.6 70 0 10.4 n n 5.2 104 108 110 0 0 0 1 0 0 0 0 0 0 2.6 7 50 51 1 60
224 jothi 32 primi 8w 155 53 22.1 74 0 10.2 n n 4.7 114 110 108 0 0 0 0 2/fd 0 0 0 0 0 2.3 7 51 52 1 59
225 priya 26 g2a1 8w3d 149 49 22.1 74 0 10.1 n n 4.6 112 102 108 0 0 0 1 0 0 1 0 0 0 2.1 7 49 48.5 -0.5 60
226 shanmugapriya 31 g2p1l1 8w4d 154 52 21.9 72 0 10 n n 5.4 99 112 106 0 0 0 0 0 0 0 0 0 0 3.4 8 52 52.5 0.5 61
227 karthika 23 primi 7w6d 152 51 22.1 74 0 9.8 n n 5.3 97 108 110 0 0 0 0 2/fpd 0 0 0 0 0 2.2 8 51 50 -1 60
228 vasanthakumari 23 g3p2l1 8w2d 148 50 22.8 75 0 10.6 n n 5.2 102 106 117 0 0 0 1 0 0 0 0 0 0 3.2 9 50 49.5 -0.5 58
229 rubini 23 primi 9w 150 49 21.8 73 0 10.2 n n 5.1 105 116 104 0 0 1 1 0 0 0 0 0 0 3.2 7 49 49 0 58
230 vaduvambal 24 g2p1l1 9w1d 153 51 21.8 77 1 10.6 n n 4 102 107 121 0 0 0 1 0 0 0 0 0 0 2.8 8 51 51.5 0.5 62
231 banumathi 22 g2p1l1 8w3d 148 48 21.9 78 0 12 n n 4.7 120 108 110 0 0 0 0 2/fpd 0 0 0 0 0 2.56 9 48 48 0 57
232 manjula 23 g2p1l1 8w5d 152 49 21.2 77 0 11.3 n n 5.4 112 112 109 0 0 0 1 0 0 0 0 0 0 2.6 8 49 48.5 -0.5 59
233 logeshwari 24 primi 9w 156 52 21.4 76 0 10.3 n n 5.3 112 109 110 0 0 0 1 0 0 0 0 0 0 2.5 8 52 52.5 0.5 62
234 bhuvaneshwari 24 g2a1 8w1d 157 56 22.7 75 0 10.4 n n 5.2 109 110 109 0 0 0 1 0 0 0 0 0 0 2.4 9 56 55 -1 65
107
235 selvi 29 primi 8w5d 151 49 21.5 72 1 9.9 n n 5.6 107 112 116 0 0 0 1 0 0 0 0 0 0 2.8 8 49 49.5 0.5 58
236 viji 27 g2a1 7w3d 149 51 23 71 0 10.2 n n 5.2 125 106 112 0 0 1 1 0 0 1 0 0 0 2.3 8 51 51.5 0.5 62
237 kalpana 29 primi 7w5d 150 53 23.6 81 0 10.6 n n 5 102 98 109 0 0 0 1 0 0 0 0 0 0 2.4 8 53 52 -1 62
238 kalaiselvi 22 primi 8w3d 147 45 20.8 74 0 10.2 n n 5.1 106 96 107 0 0 0 0 2/fd 0 0 0 0 0 2.5 8 45 46 1 55
239 rekha 23 g2p1l1 8w 151 50 21.9 72 0 9.8 n n 4.7 104 108 115 0 0 1 0 2/fd 0 0 0 0 0 3 8 50 50.5 0.5 61
240 jothi 30 primi 9w1d 149 54 24.3 71 0 10.3 n n 4.5 98 116 107 0 0 0 0 2/fd 0 0 0 0 0 2.3 7 54 53 -1 64
241 ranjani 24 primi 8w6d 151 52 22.8 73 0 10.2 n n 5.1 102 120 109 0 0 0 1 2/fd 0 0 0 0 0 2.9 8 52 52.5 0.5 62
242 madhumathi 21 g2p1l1 9w1d 154 51 21.5 75 0 10 n n 4.8 119 113 124 0 0 0 1 0 0 0 0 0 0 2.6 7 51 50.5 -0.5 60
243 thenmoghi 22 primi 8w2d 148 50 22.8 71 0 10.1 n n 4.7 111 107 117 0 0 0 1 0 0 1 0 0 0 2.2 7 54 52 -2 61
244 priya 25 primi 8w4d 156 52 21.4 74 1 10 n n 5.6 101 108 118 0 0 0 1 0 0 0 0 0 0 2.6 7 52 52.5 0.5 59
245 manimegalai 30 g3p1l1 9w2d 152 54 23.4 73 1 12 n n 5.4 112 110 124 0 0 0 1 0 0 0 0 0 0 3.1 7 54 52.5 -1.5 61
246 vanitha 27 primi 10w1d 156 52 21.4 74 0 13 n n 5 103 112 120 0 0 0 1 0 0 0 0 0 0 3.3 7 52 51.5 -0.5 65
247 thilagavathy 25 g2a1 11w 154 52 21.9 76 0 11 n n 5.2 104 114 123 0 0 0 1 0 0 0 0 0 0 2.9 8 54 52 -2 63
248 yuvasree 36 g4p1l1a2 10w3d 152 54 23.4 75 0 12 n n 6 112 112 112 0 0 0 0 0 0 0 0 0 0 2.7 8 51 51.5 0.5 62
249 anjalai 32 g3p2l2 10w 148 52 23.7 73 0 10.4 n n 6.1 102 110 124 0 0 1 1 0 0 0 0 0 0 3.1 8 54 54.5 0.5 64
250 Rajammal 29 primi 7w5d 150 53 23.6 81 0 10.6 n n 5 102 98 109 0 0 0 1 0 0 0 0 0 0 2.4 8 53 52 -1 62
0 - No 1 - Yes 2 - LSCS
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KEY TO MASTER CHART 
 
1 .GA                     - GESTATIONAL AGE 
2. HT                    -  HEIGHT  
3. WEIGHT           -  WEIGHT 
4. BMI                  -  BODY MASS INDEX 
5. W/H                - WAIST HIP RATIO 
6. F/H/DM         - FAMILY HISTORY OF DIABETES  
    MELLITUS 
7. HB                  - HAEMOGLOBIN 
8. RFT                - RENAL FUNCTION TEST 
9. LFT                -  LIVER FUNCTION TEST 
10.TM               - TRIMESTER 
11.R.FAC           - RISK FACTOR 
12. GDM/MP    - GESTATIONAL DIABETES  
    MELLITUS/MEAL PLAN 
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13.GDM/INS     - GESTATIONAL DIABETES  
    MELLITUS/INSULIN 
14.P.E                 - PRE ECLAMPSIA 
15.IOL                  - INDUCTION OF LABOUR 
16.ND                  - NORMAL DELIVERY 
17.LSCS               - LOWER SEGMENT CAESAREAN SECTION 
18.LGA                - LARGE FOR GESTATIONAL AGE 
19.SGA                - SMALL FOR GESTATIONAL AGE 
20. HYPO GLY     - HYPOGLYCAEMIA 
21.BA                     - BIRTH ASPHYXIA 
22. HYP.BIL         - HYPERBILIRUBINAEMIA 
23. PRE PREG  
      WT   - PRE PREGNANCY WEIGHT  
24.EP WT GAIN   - EARLY PREGNANCY WEIGHT GAIN 
25.T.WG                - TOTAL WEIGHT GAIN 
 
 
